Status Plus

Scientific Program

Scientific Program

Print This Page
Session type:
Person:
Clear filters

Wednesday, February 28, 2018

Afternoon

11:30 a.m. - 03:00 p.m.

2nd Japanese Society for Sexual Medicine (JSSM) symposium

Location: Room 5 A in Pavilion 5
11:30 a.m. - 11:55 a.m.

Luncheon session (lunch box will be provided)

Location: Room 5 A in Pavilion 5
Moderator: Sue Goldstein (USA)
11:30 a.m. - 11:40 a.m.
Introduction of Yokohama in Tokyo Greater Area (video)

11:40 a.m. - 11:55 a.m.
Pleasure solutions and the sexual consequences of cancer

Hilary Belcher (United Kingdom) & Ellie J. Ricketts (United Kingdom)


12:00 p.m. - 12:05 p.m.

Opening remarks

Location: Room 5 A in Pavilion 5

Mikio Namiki (Japan)


12:05 p.m. - 12:15 p.m.

Introduction of WMSM2020 Japan

Location: Room 5 A in Pavilion 5

Koichi Nagao (Japan) & Yoshikazu Sato (Japan)


12:15 p.m. - 12:45 p.m.

Basic research

Location: Room 5 A in Pavilion 5
Moderators: Maarten Albersen (Belgium) & Norifumi Sawada (Japan)

Takaki Ishida (Japan) & Tomoya Kataoka (Japan)


12:45 p.m. - 01:20 p.m.

Prostate cancer and sexual function

Location: Room 5 A in Pavilion 5
Moderators: Eric Chung (Australia) & Motostugu Oya (Japan)

Atsushi Takenaka (Japan) & Masaki Kimura (Japan)


01:20 p.m. - 01:30 p.m.

Break

Location: Pavilion 4

01:30 p.m. - 02:15 p.m.

Sexual medicine and andrology

Location: Room 5 A in Pavilion 5
Moderators: Mario Maggi (Italy), Norio Nonomura (Japan) & Osamu Yokoyama (Japan)

Shinichiro Fukuhara (Japan), Kazuyoshi Shigehara (Japan) & Fumitoshi Sakamoto (Japan)


02:15 p.m. - 03:00 p.m.

Current and future sexual medicine in Japan

Location: Room 5 A in Pavilion 5
Moderators: Toshiyasu Amano (Japan), Haruaki Sasaki (Japan) & Hikaru Tomoe (Japan)

Shinichi Hisasue (Japan), Noriko Ninomiya (Japan) & Koji Shiraishi (Japan)



12:00 p.m. - 03:00 p.m.

JSM/SMR/SMOA - Writing and reviewing workshop

Location: Auditorium III
Moderators: Irwin Goldstein (USA), John Mulhall (USA) & Kwangsung Park (Korea)

12:00 p.m. - 12:05 p.m.

Update JSM

John Mulhall (USA)

12:05 p.m. - 12:10 p.m.

Update SMR

Irwin Goldstein (USA)

12:10 p.m. - 12:15 p.m.

Update SM

Kwangsung Park (Korea)

12:15 p.m. - 12:35 p.m.

Understanding the open access policy of Sexual Medicine

Kwangsung Park (Korea)

12:35 p.m. - 12:55 p.m.

Writing a scientific paper

Annamaria Giraldi (Denmark)

12:55 p.m. - 01:15 p.m.

Writing a review paper

Irwin Goldstein (USA)

01:15 p.m. - 01:35 p.m.

Common statistical errors

Chris Nelson (USA)

01:35 p.m. - 01:45 p.m.

The manuscript submission process

Sue Goldstein (USA)

01:45 p.m. - 02:05 p.m.

Reviewing a scientific manuscript, with examples

John Mulhall (USA)

02:05 p.m. - 02:25 p.m.

How to revise a paper

Andrea Salonia (Italy)

02:25 p.m. - 03:00 p.m.

Q&A


12:00 p.m. - 03:00 p.m.

SFMS symposium (in French)

Location: Auditorium II
Moderators: Robert Andrianne (Belgium) & Pierre Bondil (France)
12:00 p.m. - 12:55 p.m.

Premature ejaculation/ ejaculation prématurée

Location: Auditorium II
12:00 p.m. - 12:20 p.m.
Epidemiological data interest in premature ejaculation /Intérêt des données épidémiologiques dans l’éjaculation prématurée

Eric Huyghe (France)

12:20 p.m. - 12:40 p.m.
Value of bibliotherapy in premature ejaculation/ Valeur de la Bibliothérapie dans l’ejaculation précoce

Robert Andrianne (Belgium) & Philippe Kempeneers (Belgium)

12:40 p.m. - 12:55 p.m.
Discussion


01:00 p.m. - 01:40 p.m.

News in sexual medicine

Location: Auditorium II
Moderator: Pierre Bondil (France)
01:00 p.m. - 01:20 p.m.
What is news on priapism/quelles nouveautés dans le priapisme

Pierre Bondil (France)

01:20 p.m. - 01:40 p.m.
Top 10 news in sexual medicine/ top 10 des nouvelles en medecine sexuelle

Jean Pierre Graziana (France) & Charlotte Methorst (France)


01:40 p.m. - 02:55 p.m.

Pain in sexual medicine/ La douleur en médecine sexuelle

Location: Auditorium II
Moderator: Sandrine Atallah (Lebanon)
01:40 p.m. - 02:00 p.m.
Pathophysiology of chronic pain in sexual medecine/ Pathophysiologie de la douleur en medecine sexuelle

Philippe Laribeau (France)

02:00 p.m. - 02:20 p.m.
Sexual arousal: from pleasure to pain or « grey of shades »/L’exitation sexuelle: du plaisir à la douleur ou les « nuances de gris »

Laure Grellet (France)

02:20 p.m. - 02:40 p.m.
Unconsomned marriages in Middle East countries/ les mariages non consommés au Moyen Orient

Sandrine Atallah (Lebanon)

02:40 p.m. - 02:55 p.m.
Discussion


02:55 p.m. - 03:00 p.m.

Conclusions

Location: Auditorium II
Moderators: Carol Burte (France), Béatrice Cuzin (France) & Eric Huyghe (France)


12:00 p.m. - 03:00 p.m.

MESSM symposium - Separating fact from fiction in sexual medicine

Location: Auditorium IV

12:00 p.m. - 12:05 p.m.

Welcome note and introduction

12:05 p.m. - 12:25 p.m.

Nonmedical management of refractory premature ejaculation: what is the role?

Amr El-Meliegy (Egypt)

12:25 p.m. - 12:45 p.m.

Off label use of collagenase clostridium histolyticum injection in Peyronie's disease

Amr Abdelraheem (Egypt)

12:45 p.m. - 12:50 p.m.

Questions and comments

12:50 p.m. - 01:00 p.m.

Break

01:00 p.m. - 01:20 p.m.

Female genital cutting: the fate of female sexual function?

Tarek Anis (Egypt)

01:20 p.m. - 01:40 p.m.

Female sexual dysfunction treatments: what works and what doesn’t

Sandrine Atallah (Lebanon)

01:40 p.m. - 01:45 p.m.

Questions and comments

01:45 p.m. - 02:00 p.m.

Break

02:00 p.m. - 02:15 p.m.

Stem cell therapy in andrology facts & fictions

Amjad Alwaal (Saudi Arabia)

02:15 p.m. - 02:30 p.m.

LISWT for ED: does it work?

Jawad Feghali (Lebanon)

02:30 p.m. - 02:45 p.m.

Chronic prostatitis/chronic pelvic pain syndrome and sexual dysfunction

Naif Al-Hathal (Saudi Arabia)

02:45 p.m. - 02:55 p.m.

Questions and comments

02:55 p.m. - 03:00 p.m.

Closing remarks


12:00 p.m. - 03:00 p.m.

ASESA/SPA symposium (in Spanish / Portuguese)

Location: Auditorium I
12:00 p.m. - 12:20 p.m.

Sessão/Sesión: Infertilidade: questões éticas na escolha do gâmeta perfeito

Location: Auditorium I
Moderators: Luis Ferraz (Portugal) & Ferran García José (Spain)
12:00 p.m. - 12:20 p.m.
Infertilidad: cuestiones éticas en la elección del gameto perfecto

Nuno Louro (Portugal)


12:25 p.m. - 01:10 p.m.

Sessão de vídeos/Sesión de video - Cirugia reconstrutiva na medicina sexual

Location: Auditorium I
Moderators: Juan Ignacio Martinez-Salamanca (Spain) & João Nuno Tomada (Portugal)
12:30 p.m. - 12:40 p.m.
Corporoplastia de aumento multislice

Paulo Egydio (Brazil)

12:40 p.m. - 12:50 p.m.
Incision y cobertura con Colageno Autólogo

Enrique Lledó García (Spain)

12:50 p.m. - 01:00 p.m.
Uso de tachosyl com e sem prótese peniana

Augusto José Pepe Cardoso (Portugal)

01:00 p.m. - 01:10 p.m.
Cirugia de transsexualismo female-to-male

Javier Romero-Otero (Spain)


01:10 p.m. - 01:20 p.m.

Algoritmo de manejo de la Enfermedad de Peyronie compleja asociada a disfunción eréctil

Location: Auditorium I
01:10 p.m. - 01:20 p.m.

Juan Ignacio Martinez-Salamanca (Spain)


01:20 p.m. - 01:30 p.m.

Tratamiento de la incurvación peneana congénita ventral del adulto

Location: Auditorium I
01:20 p.m. - 01:30 p.m.

Fernando Meijide Rico (Spain)


01:30 p.m. - 02:30 p.m.

Sessão/Sesión: Não respondedores aos I PDE5- No-respondedores a IPDE5

Location: Auditorium I
Moderators: Ignacio Moncada-Iribarren (Spain) & Pedro Vendeira (Portugal)
01:30 p.m. - 01:45 p.m.
¿Quem são? ¿Quiénes son?

Bruno Pereira (Portugal)

01:45 p.m. - 01:55 p.m.
O que podemos esperar da ciência básica - ¿Qué podemos esperar de la ciencia básica?

Javier Angulo Cuesta (Spain)

01:55 p.m. - 02:10 p.m.
Papel do hipogonadismo - Papel del hipogonadismo-

Pedro Eufrásio (Portugal)

02:10 p.m. - 02:20 p.m.
Alternativas terapéuticas - Litotrícia por ondas de choque

Rafael Prieto Castro (Spain)


02:30 p.m. - 02:40 p.m.

Validación cuestionario PDQ para la evaluación de la Enfermedad de Peyronie

Location: Auditorium I
02:30 p.m. - 02:40 p.m.

Borja García Gómez (Spain)


02:40 p.m. - 03:00 p.m.

Conferência Magistral

Location: Auditorium I
02:40 p.m. - 03:00 p.m.
Imagiologia em Andrologia- Imagen Ecográfica en Andrología

Eugenio Cerezo (Spain)



01:00 p.m. - 05:30 p.m.

The Fourth World Chinese Andrology and Sexual Medicine symposium

Location: Room 5 B/C in Pavilion 5
01:00 p.m. - 01:15 p.m.

Welcome speeches

Location: Room 5 B/C in Pavilion 5

Luca Incrocci (The Netherlands), Yacov Reisman (The Netherlands) & Run Wang (USA)


01:15 p.m. - 01:35 p.m.

Opening ceremony of Global Chinese Andrology and Sexual Medicine Association (GCASMA)

Location: Room 5 B/C in Pavilion 5

Hui Jiang (China)


01:35 p.m. - 02:20 p.m.

Session I

Location: Room 5 B/C in Pavilion 5
Moderators: Huiliang Zhou (China), Bang-Ping Jiann (Taiwan) & Ronny Tan (Singapore)
01:35 p.m. - 01:50 p.m.
The development of Chinese andrology and sexual medicine

Hui Jiang (China)

01:50 p.m. - 02:00 p.m.
Global urology/andrology-China’s great contributions

Philip Li (China)

02:00 p.m. - 02:10 p.m.
New strategy of the diagnosis and treatment of PPE

Yutian Dai (China)

02:10 p.m. - 02:20 p.m.
Peyronies’disease: treatment with injection Xiapex

Yuhui Wang (China)


02:20 p.m. - 03:00 p.m.

Session II

Location: Room 5 B/C in Pavilion 5
Moderators: Yan Zhang (China), Yuhui Wang (China) & Tao Jiang (China)
02:20 p.m. - 02:30 p.m.
Preserved erectile function in the hyperhomocysteinaemia transgenic rats harboring human tissue kallikrein 1

Jihong Liu (China)

02:30 p.m. - 02:40 p.m.
Modern Western vs. traditional Chinese medicines: yin and yang in ED treatment

Eric Chung (Australia)

02:40 p.m. - 02:50 p.m.
Tadalafil, dapoxetine alone or in combination for the treatment combined with premature ejaculation

Huiliang Zhou (China)

02:50 p.m. - 03:00 p.m.
Penile prosthesis for the Asian man

Ronny Tan (Singapore)


03:00 p.m. - 03:10 p.m.

Coffee break

Location: Foyer D

03:10 p.m. - 03:40 p.m.

Session III

Location: Room 5 B/C in Pavilion 5
Moderators: Zhichao Zhang (China), Eric Chung (Australia) & Xiangsheng Zhang (China)
03:10 p.m. - 03:20 p.m.
The new classification system and clinic application of venous leakage erectile dysfunction

Yun Chen (China)

03:20 p.m. - 03:30 p.m.
Sexual dysfunction in men with Klinefelter’s syndrome

Hong-Chiang Chang (Taiwan)

03:30 p.m. - 03:40 p.m.
Stem leydig cell therapy for late-onset hyppgonadism

Xiangzhou Sun (China)


03:40 p.m. - 04:20 p.m.

Session IV

Location: Room 5 B/C in Pavilion 5
Moderators: Zhong Wang (China), Yun Chen (China) & Xiangzhou Sun (China)
03:40 p.m. - 03:50 p.m.
The challenge of testicular pathology in microTESE-ICSI era

William J. Huang (Taiwan)

03:50 p.m. - 04:00 p.m.
Behavioural therapy for premature ejaculation

Yan Zhang (China)

04:00 p.m. - 04:10 p.m.
Penile Implant under local anesthesia: tips and limitations

Sung Hun Park (Korea)

04:10 p.m. - 04:20 p.m.
The status and progress of Chinese andrology based on real cases

Tao Jiang (China)


04:20 p.m. - 05:00 p.m.

Session V

Location: Room 5 B/C in Pavilion 5
Moderators: Junhong Deng (China), William J. Huang (Taiwan) & Rui Jiang (China)
04:20 p.m. - 04:30 p.m.
A survey of women’s fake orgasm and its correlation with unpleasant sexual experiences

Yu Chen (Taiwan)

04:30 p.m. - 04:40 p.m.
Seminal dysbiosis is associated with low seminal quality in varicocele patients

Xiaodong Jin (China)

04:40 p.m. - 04:50 p.m.
The treatment strategy of penoscrotal extramammary Pagets’s Disease

Haijun Yao (China)

04:50 p.m. - 05:00 p.m.
Circumcision current situation in China- from China primary hospital

Hu Li (China)


05:00 p.m. - 05:30 p.m.

Session VI

Location: Room 5 B/C in Pavilion 5
Moderators: Yu Chen (Taiwan), Hang Li (China) & Yong Gao (China)
05:00 p.m. - 05:10 p.m.
Preliminary study on the central mechanism of psychogenic erectile dysfunction using MRI

Xiangsheng Zhang (China)

05:10 p.m. - 05:15 p.m.
Adolescent caricocele: debate in diagnosis and treatment

Shangchao Zhao (China)

05:15 p.m. - 05:20 p.m.
Concealed penis treatment

Xinjun Shu (China)

05:20 p.m. - 05:25 p.m.
The application potential of the Extracellular Vesicles in erectile dysfunction

Haocheng Lin (China)

05:25 p.m. - 05:30 p.m.
Q&A and closing remarks

Run Wang (USA), Hui Jiang (China) & Bang-Ping Jiann (Taiwan)



03:00 p.m. - 03:30 p.m.

Coffee break

Location: Foyer D

03:30 p.m. - 05:00 p.m.

ICSM session

Location: Auditorium II
Moderator: Gerald Brock (Canada)

03:30 p.m. - 03:50 p.m.

Prostate cancer survivorship: Consensus statement and clinical practice recommendations on sexual health, function and rehabilitation

Eric Chung (Australia)

03:50 p.m. - 04:15 p.m.

Discussion

04:15 p.m. - 04:35 p.m.

Testosterone update 2018

Abraham Morgentaler (USA), Hugh Jones (United Kingdom) & Abdulmaged Traish (USA)

04:35 p.m. - 05:00 p.m.

Discussion


03:30 p.m. - 05:00 p.m.

Young Sexual Medicine Academy

Location: Auditorium IV
Moderators: Yacov Reisman (The Netherlands) & Selcuk Sarikaya (Turkey)

03:30 p.m. - 03:40 p.m.

Introduction of YoSeMA

Selcuk Sarikaya (Turkey)

03:40 p.m. - 04:00 p.m.

ESSM target and vision and The ESSM Perspective towards Young Sexologists and sexual medicine physicians

Yacov Reisman (The Netherlands)

04:00 p.m. - 05:00 p.m.

Cases that matter

Francois Giuliano (moderator) (France), Dimitrios Hatzichristou (moderator) (Greece), Maarten Albersen (Belgium), Marco Falcone (Italy), Mikkel Fode (Denmark), Giorgios Pagkalos (Greece), Charmaine Borg (The Netherlands), Fabio Castiglione (Italy), Omer Onur Cakir (Turkey) & Marta Skrodzka (Poland)


03:30 p.m. - 05:30 p.m.

VJPU workshop - Basic prosthetic techniques (non CME)

Location: Auditorium I
Moderator: Steven Wilson (USA)

03:30 p.m. - 03:40 p.m.

Equipment needed and how to make your own surgical videos

Andrew Kramer (USA)

03:40 p.m. - 03:50 p.m.

Operative set up for inflatable penile prosthesis

Ashley Tapscott (USA)

03:50 p.m. - 04:00 p.m.

Tips and tricks of penoscrotal incision IPP

Ryan Terlecki (USA)

04:00 p.m. - 04:10 p.m.

New thoughts on cylinder sizing

Andrew Kramer (USA)

04:10 p.m. - 04:20 p.m.

Traditional & ectopic reservoir placement IPP & AUS

Daniar Osmonov (Germany)

04:20 p.m. - 04:30 p.m.

Insertion of IPP into neophallus

David Ralph (United Kingdom)

04:30 p.m. - 04:40 p.m.

Tips and tricks of revision surgery

Andrew Kramer (USA)

04:40 p.m. - 04:50 p.m.

Subcoronal IPP with patch graft of ventral Peyronie’s

Rafael Carrion (USA)

04:50 p.m. - 05:00 p.m.

Tips and tricks of scrotal incision AUS

Steven Wilson (USA)

05:00 p.m. - 05:10 p.m.

Tips and tricks of perineal incision AUS

Koenraad Van Renterghem (Belgium)

05:10 p.m. - 05:20 p.m.

How to Perform an IPP Under Local Anesthesia

Sung Hun Park (Korea)

05:20 p.m. - 05:30 p.m.

Dorsal phalloplasty and monsplasty for lengthening

Osama Shaeer (Egypt)


03:30 p.m. - 05:30 p.m.

KSSMA symposium

Location: Auditorium III
03:30 p.m. - 03:35 p.m.

Welcome remarks and introduction

Location: Auditorium III

Dae Yul Yang (Korea), Luca Incrocci (The Netherlands) & Run Wang (USA)


03:35 p.m. - 04:30 p.m.

Premature ejaculation I

Location: Auditorium III
Moderators: Zhong-Cheng Xin (China), Woo Sik Chung (Korea) & Ki Hak Moon (Korea)
03:35 p.m. - 03:50 p.m.
Prevalence and characteristics of PE in Korean males

Hwancheol Son (Korea)

03:50 p.m. - 04:00 p.m.
Diagnosis and treatment of PE in Korea

Sang Kuk Yang (Korea)

04:00 p.m. - 04:15 p.m.
Efficacy and safety of dapoxetine in the treatment of PE

Heung Jae Park (Korea)

04:15 p.m. - 04:30 p.m.
Other pharmacological treatment for PE

Myong Kim (Korea)


04:30 p.m. - 05:30 p.m.

Premature ejaculation II

Location: Auditorium III
Moderators: Trinity Bivalacqua (USA), Jae-Seung Paick (Korea) & Sae Woong Kim (Korea)
04:30 p.m. - 04:45 p.m.
New therapeutic targets and emerging drugs

Yu Seob Shin (Korea)

04:45 p.m. - 05:00 p.m.
Surgical treatment for PE

Hong Seok Shin (Korea)

05:00 p.m. - 05:30 p.m.
Panel discussion with clinical case

Seung-Hun Song (Korea), Kweon Sik Min (Korea), Min Chul Cho (Korea), Shinichi Hisasue (Japan) & Kyung Hyun Moon (Korea)



Evening

05:30 p.m. - 07:00 p.m.

ESSM business meeting (members only)

Location: Auditorium II

Thursday, March 1, 2018

Morning

07:30 a.m. - 08:30 a.m.

Sponsored breakfast symposium (non-CME)

Location: Auditorium II

08:30 a.m. - 10:00 a.m.

Male sexual dysfunction

Location: Auditorium I
Moderators: Sidney Glina (Brazil) & Lawrence Hakim (USA)

08:30 a.m. - 09:00 a.m.

Total phallic reconstruction

David Ralph (United Kingdom)

09:00 a.m. - 09:30 a.m.

The new algorythm for the treatment of Peyronie's Disease

Eric Chung (Australia)

09:30 a.m. - 10:00 a.m.

Testosterone treatment, indications and safety

Mario Maggi (Italy)


08:30 a.m. - 10:00 a.m.

ESSM grant reports

Location: Auditorium II
Moderators: Javier Angulo Frutos (Spain) & Trinity Bivalacqua (USA)

The endogenous neurotrophin galanin as a strategy for erectile function rehabilitation after radical prostatectomy

Emmanuel Weyne (Belgium)

Development of a decision aid for genital surgery in transmen

Mujde Ozer (The Netherlands)

Discovery of novel drugs for Peyronie’s disease through phenotypic screening

Selim Cellek (United Kingdom)


08:30 a.m. - 10:00 a.m.

Podium session 1 - Female sexual function

Location: Room 5 B/C in Pavilion 5
Moderators: Kwangsung Park (Korea) & Mona Reda (Egypt)

The importance of male ejaculation for female sexual satisfaction and orgasm ability (#001)

Andrea Burri (United Kingdom)

Preliminary validation of the short symptom screener for women (SCS-W) (#002)

Andrea Burri (United Kingdom)

Effects of age on the subjective sexual response and emotional appraisal of sex pictures in women (#003)

J. Carvalho (Portugal)

Sexual dysfunctions in a sample of female Egyptians diagnosed with obsessive compulsive disorder (#004)

Mona Reda (Egypt)

The effects of learned sex-disgust associations on female sexual response (#005)

Charmaine Borg (The Netherlands)

Genital and subjective sexual response in women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a non-surgically created neo-vagina (#006)

P. Weijenborg (The Netherlands)

Bremelanotide (BMT) for hypoactive sexual desire disorder (HSDD): efficacy analyses from the RECONNECT studies (#007)

Anita Clayton (USA)

Bremelanotide provides meaningful treatment benefits for premenopausal women with hypoactive sexual desire disorder (#008)

J. Lucas (USA)

Comparing symptom networks of women with reduced, increased, and stable sexual desire (#009)

A. Gunst (Finland)

Reversible neurogenic sexual dysfunction caused by lumbar and/or sacral pathology within the cauda equina (#010)

Irwin Goldstein (USA)

Pilot prospective vulvoscopic study examining changes to the vulva, vestibule, and vagina in women with genitourinary syndrome of menopause taking ospemifene (#011)

Sue Goldstein (USA)

Sexual function in women with obstetric anal sphincter injuries in the postpartum period. Analysis according to the mode of delivery (#012)

S.A.A. Anglès (Spain)

Alternative rights of passage: a new model to end FGM (#013)

J. Osur (Kenya)

Do experts for vulva diseases integrate sexual health problems in daily diasease-managment _ self-assessment results at the 10th anniversary of the interdisciplinarey Vulva-Workshop, VIVE-EV_Graz, September 2017 (#014)

B. Eberz (Austria)

A randomized, wait list-controlled trial suggests that two psychobehavioral interventions are effective for women’s hypoactive sexual desire (#015)

Patrick Jern (Finland)


09:00 a.m. - 10:00 a.m.

WAS symposium - From sexual science to sexual health and sexual rights

Location: Auditorium III
Moderator: Pedro Nobre (Portugal)

09:00 a.m. - 09:20 a.m.

The World Association for Sexual Health: Promoting evidence-based sexual health and sexual rights

Pedro Nobre (Portugal)

09:20 a.m. - 09:40 a.m.

The full gamut of sexual health care

Woet Gianotten (The Netherlands)

09:40 a.m. - 10:00 a.m.

Sexual pleasure, a sexual right often neglected in research

Patricia Pascoal (Portugal)


10:00 a.m. - 10:30 a.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

10:00 a.m. - 10:30 a.m.

Moderated poster tour 1 - Sexual identity (orientation), gender identity and sexual preference

Location: Pavilion 5
Moderators: Alan Shindel (USA) & Kevan Wylie (United Kingdom)

Neural mechanisms underlying pedophilia and sexual offending against children - first results of a multicenter study (#201)

J. Engel (Germany)

Development, validation, and results from a novel inventory to assess and compare gender dysphoria before and after genital gender affirming surgery (#202)

M. Garcia (USA)

Barriers to post-transgender surgery care in the federal prison system (#203)

M. Garcia (USA)

The “functional magnetic resonance imaging” (fMRI) as a meaningful tool for the differentiation of sexual preferences (#204)

J.L. Kunath (Germany)

A longitudinal study of motivations before and psychosexual outcomes after genital gender confirming surgery in transmen (#205)

Tim van de Grift (The Netherlands)

Influence of partner sexuality on the sexual activity of aged men and women (#206)

N. Ati (Tunisia)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 2 - Priapism & Peyronie's disease

Location: Pavilion 5
Moderators: Emre Akkus (Turkey) & Osama Shaeer (Egypt)

The Comparison of an acellular matrix graft (Xenoguardtm) with an autologous venous graft in the surgical treatment of Peyronie’s Disease (#207)

O. Kayigil (Turkey)

Preliminary outcomes of Collagenase Clostridium Histolyticum (CCH) using a modified technique “Percutaneous Needling Tunneling (PNT)” in the treatment of Peyronie's Disease (PD): prospective randomized study (#208)

E. Fernández-Pascual (Spain)

Peyronie’s Disease : predictive factors of good response to collagenase clostridium hystoliticum injections therapy (#209)

Marco Capece (Italy)

Novel injection method using a Collagenase Clostridium histolyticum in Peyronie’s Disease (#210)

Z. Zotter (Hungary)

Ultrasound predictive factors for efficacy and safety of the use of Collagenase Clostridium Histolyticum (CCH) in the treatment of Peyronie's disease (PD): Impact of patient´s selection (#211)

E. Fernández-Pascual (Spain)

Emergency room visits are reduced in patients using type 5 phosphodiesterase inhibitors for recurrent priapism (#212)

E. Rajih (Saudi Arabia)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 3 - Basic research 1

Location: Pavilion 5
Moderators: Ganesh Adaikan (Singapore), Fabio Castiglione (Italy) & Kelvin Davies (USA)

Nrf2 activation improves both hyperpolarization- and NO-mediated responses in penile vasculature from patients with erectile dysfunction (#213)

J. Angulo (Spain)

Efficient promotion of autophagy and angiogenesis by combination therapy with low-energy shockwaves and mesenchymal stem cells in the treatment of erectile dysfunction (#214)

W.J. Bae (Korea)

Mechanisms underlying the sexual inhibitory effect of tramadol; a study in serotonin transporter knockout rats (#215)

D.C. Esquivel Franco (The Netherlands)

Functional effects of the monoamine reuptake inhibitor, IPED2015 in both cerebral and erectile tissue in vitro (#216)

S. Comerma-Steffensen (Denmark)

Neuropraxia following nerve sparing radical prostatectomy is associated with increased expression of markers of inflammation and Fidgetin-2 like protein (#217)

G. Villegas (USA)

Inhibition of microRNA-92a improved erectile dysfunction in streptozotocin-induced diabetic rats via suppressing oxidative stress and endothelial dysfunction (#218)

Z. Tang (China)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 4 - ED: epidemiology

Location: Pavilion 5
Moderators: Sae Woong Kim (Korea) & John Mulhall (USA)

Probability of erectile function recovery in young men treated with radical prostatectomy – findings of a contemporary series (#219)

W. Cazzaniga (Italy)

Temporal trend in patients’ age at first assessment for erectile dysfunction (#220)

Eugenio Ventimiglia (Italy)

Erectile dysfunction and associated risk factors in infertile Chinese men (#221)

Y. Bin (China)

Global prevalence, patient profiles, and health outcomes of erectile dysfunction (ED) among 40-70 year-old men (#222)

Irwin Goldstein (USA)

Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy (#223)

W. Cazzaniga (Italy)

Sexual dysfunction among Greek patients with multiple sclerosis (#224)

M. Tzitzika (Greece)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 5 - Ejaculation and its associated problems

Location: Pavilion 5
Moderators: Shinichi Hisasue (Japan) & Kevin McVary (USA)

Vacuum therapy in ED: outcomes from a specialist vacuum clinic (#225)

S.J. Megarity (United Kingdom)

Sexuality in adult male patients with anorectal malformations (#226)

S. Eleuteri (Italy)

The effect of buspirone on refractory neurogenic retrograde ejaculation to pseudoephedrine (#227)

S.T. Ahn (Korea)

Lower urinary tract symptoms among patients presenting for premature ejaculation (#228)

Andrea Salonia (Italy)

How does premature ejaculation affect erectile function? (#229)

J. Peng (China)

Metabolic syndrome is an independent risk factor for acquired premature ejaculation (#230)

S.U. Jeh (Korea)


10:30 a.m. - 11:00 a.m.

Late breaking abstracts

Location: Auditorium II
Moderators: Kwangsung Park (Korea) & Guy T'Sjoen (Belgium)

Tadalafil 5 mg effectiveness in the treatment of lower urinary tract symptoms suggestive to benign prostatic hyperplasia with erectile dysfunction (#165)

N. Ati (Tunisia)

Enjoy yourself, it's later than you think! (#166)

S.J. Megarity (United Kingdom)

Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials (#167)

K. van Rooij (The Netherlands)

Effect of a Trigonella foenum graecum-based food supplement on sexual function in women with low sexual desire. Pilot study (#168)

M. Lilue (Spain)

Do international experts in fertility preservation adress sexual problems in fertility-treatment? Igls-Vienna-SexMed-Survey-Program: Reproductive Medicine Experts' Self-Assessment-Results at the 5th biennal World Congress for Fertility Preservation, Vienn

L. Ucsnik (Austria)


10:30 a.m. - 11:30 a.m.

Workshop: Step care approach for managing premature ejaculation

Location: Auditorium III
Faculty: Evie Kirana (Greece) & Ege Can Serefoglu (Turkey)

10:30 a.m. - 12:30 p.m.

Podium session 2 - Basic research

Location: Room 5 B/C in Pavilion 5
Moderators: Johanna Hannan (USA) & Hotaka Matsui (Japan)

Antifibrotic effect of mycophenolate mofetil experimentally induced Peyronie's Disease with TGF-B (#016)

F.N. Facio Junior (Brazil)

Anti-fibrotic properties of RhoA kinase-inhibition in a cell culture model of Peyronie’s Disease (#017)

U. Milenkovic (Belgium)

Antagonizing penile smooth muscle contraction by inhibition of orai calcium channels. A potential therapeutic target in erectile dysfunction (#018)

J. Angulo (Spain)

Galanin mediates endogenous nitrinergic nerve outgrowth in vitro and partially restores erectile function after cavernous nerve injury in vivo (#019)

Emmanuel Weyne (Belgium)

Prostatic radiation therapy increases neuronal apoptosis, decreases nitrergic neurons and markedly impairs neuritogenesis in the major pelvic ganglion (#020)

Johanna Hannan (USA)

Potential role of 5-HT serotonin system in the rat spinal cord of premature ejaculation with category III prostatitis (#021)

Y. Zhang (China)

Vardenafil and Tamoxifen synergise in a rat model of Peyronie’s disease (#022)

M.M. Ilg (United Kingdom)

Persistent erectile dysfunction after discontinuation of 5-alpha reductase inhibitor therapy in rats depending on the duration of treatment (#023)

S.W. Lee (Korea)

JAK2 knockout improves erectile function in diabetic mice through attenuation of fibrosis and apoptosis (#024)

H. Li (China)

Dickkopf2 reprograms damaged erectile tissue toward neurovascular repair through an angiopoietin-1-Tie2 pathway in mice with diabetes mellitus or cavernous nerve injury (#025)

J.K. Suh (Korea)

Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine (ADMA) and oxidative stress in castrated rats (#026)

Tomoya Kataoka (Japan)

Mirabegron elicits recovery of erectile function in a rat model of streptozotocin-induced diabetes (#027)

E. Kaya Sezginer (Turkey)

TNF-alpha inhibition can prevent smooth-muslce dysfunction following bilateral cavernous nerve injury by upregulating GFAP expression through activation of ERK1/ERK2 signaling (#028)

Hotaka Matsui (Japan)

A novel dopamine reuptake inhibitor, IPED2015 induces spontaneous erections through activation of dopamine receptors in rats (#029)

S. Comerma-Steffensen (Denmark)

Light-controlled relaxation of rat penile corpus cavernosum by a novel NO donor, NO-Rosa (#030)

Y. Hotta (Japan)

Low intensity-shockwave therapy (Li-ESWT) delivered by Aries® improves erectile function and decreases cavernosal fibrosis of spontaneously hypertensive rats (SHR) (#031)

Francois Giuliano (France)

An evolving hypothesis on the mechanism and efficacy of intracavernosal injection of botulinum toxin to improve erectile function: an animal study in aging rats (#032)

N. Punjani (Canada)

Effect of testosterone on vaginal function in an experimental rat model (#033)

E. Maseroli (Italy)

Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction (#034)

M.T. Tar (USA)

The mechanisms of stress-induced erectile dysfunction; a focus on regulators of contraction and relaxation in the corpus cavernosum by using a rat model of water immersion-restraint stress (#035)

T. Mori (Japan)


10:30 a.m. - 12:30 p.m.

Sponsored live surgery (non-CME)

Location: Auditorium I

11:00 a.m. - 12:30 p.m.

Round table - Hypersexuality, a 2018 update

Location: Auditorium II
Moderators: Pedro Nobre (Portugal), Miguel Rivero (Argentina) & Chiara Simonelli (Italy)

11:00 a.m. - 11:15 a.m.

Sexual addiction and its relation to forensic psychiatry

Peer Briken (Germany)

11:15 a.m. - 11:30 a.m.

Is high sexual desire a risk for women's relationship and sexual well-being?

Chiara Simonelli (Italy)

11:30 a.m. - 11:45 a.m.

Emotional dysregulation and hypersexuality – Clinical implications

Mohammad Shamsul Ahsan (Bangladesh)

11:45 a.m. - 12:00 p.m.

Neurobiological basis of hypersexuality

James Pfaus (Canada)

12:00 p.m. - 12:30 p.m.

Q&A/discussion


11:30 a.m. - 12:30 p.m.

Workshop: Sex design: What the practitioner needs to know about female genital aesthetic interventions and vaginal rejuvination

Location: Auditorium III
Faculty: Michael Krychman (USA) & Lior Lowenstein (Israel)

Afternoon

12:30 p.m. - 02:00 p.m.

Lunch break

Location: Pavilion 4

02:00 p.m. - 03:00 p.m.

Sexually transmitted diseases, risk groups and prevention

Location: Auditorium I
Moderators: Abdulaziz Baazeem (Saudi Arabia), Odunayo Kalejaiye (United Kingdom) & Sérgio Tavares dos Santos (Portugal)

02:00 p.m. - 02:15 p.m.

Epidemiology of STI in 2018: a global perspective

Melanie Taylor (United Kingdom)

02:15 p.m. - 02:30 p.m.

Are risk groups evolving? Who should be screened in 2018?

Alan Shindel (USA)

02:30 p.m. - 02:45 p.m.

HIV pre- and post exposure prophylaxis: who, what, when?

Shalini Andrews (United Kingdom)

02:45 p.m. - 03:00 p.m.

HPV: a preventable cause of cancer

Ira Sharlip (USA)


02:00 p.m. - 03:00 p.m.

Workshop: Penile cancer: Treatment options and sexual consequences

Location: Auditorium III
Faculty: Asif Muneer (United Kingdom) & Arie Parnham (United Kingdom)

02:00 p.m. - 04:00 p.m.

State of the art in male orgasm disorders

Location: Auditorium II
Moderators: Francois Giuliano (France), Emmanuele Jannini (Italy) & Augusto José Pepe Cardoso (Portugal)

02:00 p.m. - 02:30 p.m.

Novelty in PE treatment (non-CME)

Vincenzo Mirone (Italy)

02:30 p.m. - 02:45 p.m.

A deeper insight in lifelong PE - The epidemiology of subjective PE

Ege Can Serefoglu (Turkey)

02:45 p.m. - 03:00 p.m.

A deeper insight in lifelong PE - The formulation of a new mathematical model for research of the phenotype and genotype of lifelong PE

Paddy Janssen (The Netherlands)

03:00 p.m. - 03:15 p.m.

A deeper insight in lifelong PE - Translational research in PE: from animal to human data

Eelke Snoeren (Norway)

03:15 p.m. - 03:30 p.m.

Debate on topical therapy: Research of local anesthetics for men with Subjective PE should not be investigated in men with Lifelong PE

Marcel Waldinger (The Netherlands)

03:30 p.m. - 03:45 p.m.

Debate on topical therapy: Local anesthetics and coated condoms are a valuable asset in the treatment of lifelong PE

Michael Butcher (USA)

03:45 p.m. - 04:00 p.m.

Male anorgasmia: causes and treatment options

Stacy Elliott (Canada)


02:00 p.m. - 04:00 p.m.

Advancing care for women with female sexual dysfunction

Location: Room 5 B/C in Pavilion 5
Moderators: Leen Aerts (Switzerland), Andrea Burri (United Kingdom) & Anita Clayton (USA)

02:00 p.m. - 02:15 p.m.

From a treatment perspective, should we separate the different types of female sexual dysfunction?

Annamaria Giraldi (Denmark)

02:15 p.m. - 02:30 p.m.

Easy to implement evidence-based strategies for the assessment and treatment of female hypoactive sexual desire disorder

Sue Goldstein (USA)

02:30 p.m. - 02:45 p.m.

Hormonal and non-hormonal pharmacological strategies to manage orgasm dysfunction, post-orgasmic illness and orgasmic anhedonia

Johannes Bitzer (Switzerland)

02:45 p.m. - 03:00 p.m.

IUGA Lecture: Physiotherapy for Sexual pain disorders in women

Bary Berghmans (The Netherlands)

03:00 p.m. - 03:15 p.m.

Same body, different approach: mindfulness in female sexual dysfunction management

Agnes Kocsis (United Kingdom)

03:15 p.m. - 03:30 p.m.

What are the educational requirements for physicians to better manage female sexual dysfunction

Sharon Parish (USA)

03:30 p.m. - 04:00 p.m.

Case discussion


03:00 p.m. - 03:30 p.m.

Sponsored session (non CME)

Location: Auditorium I

03:00 p.m. - 04:00 p.m.

Workshop: Combination-therapies in MSD (ED and EjD) - Which may fit for whom

Location: Auditorium III
Faculty: Hartmut Porst (Germany) & Hossein Sadeghi-Nejad (USA)

03:30 p.m. - 04:00 p.m.

Penile transplantation

Location: Auditorium I
Moderators: Trinity Bivalacqua (USA) & Nikolai Sopko (USA)

03:30 p.m. - 04:00 p.m.

Penile transplantation

Andre Vandermerwe (South Africa)


04:00 p.m. - 04:30 p.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

04:00 p.m. - 04:30 p.m.

Moderated poster tour 6 - Sex and biomedical issues

Location: Pavilion 5
Moderators: Woet Gianotten (The Netherlands), Sidney Glina (Brazil) & Alexander Pastuszak (USA)

Common and uncommon complications after M to F gender affirming genital surgery with vaginoplasty (#231)

M. Garcia (USA)

Efficacy and safety of Volus (hyaluronic acid) for penile girth enhancement: multi-center, randomized, subject blind, active controlled study (#232)

K. Ko (Korea)

Relationship between different types of urinary incontinence and coital incontinence in sexually active women (#233)

D.J. Nale (Serbia and Montenegro)

Serum reactivity to human Hsp60 in women with pelvic inflammatory diseases and sexual dysfunctions (#234)

O. Romashchenko (Ukraine)

Quality of life and sexuality before and 6 months after surgery in breast cancer - a study within the itop trial, a prospective trial evaluating cosmetic and oncologic outcome of immediate techniques of oncoplastic surgery in breast cancer (#235)

L. Maghörndl (Austria)

Sexual dysfunction and marital satisfaction in multiple sclerosis (#236)

M.A. Ramezani (Iran)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 7 - ED: surgical therapy 1

Location: Pavilion 5
Moderators: Daniel Chevallier (France) & Run Wang (USA)

Prosthesis-specific survey: characterizing sexual quality of life in men with a 3-piece penile prosthesis (#237)

E.C. Carlos (USA)

A case series of patients underwent laparoscopic extra-peritoneal radical prostatectomy with simultaneous implant of penile prosthesis: focus on penile length preservation (#238)

Andrea Cocci (Italy)

Glanspexy for floppy glans - outcomes and patient satisfaction (#239)

Marta Skrodzka (Poland)

Surgical outcome and patient’ satisfaction after ZSI 475 penile prosthesis implantation (#240)

V. Vagnoni (Italy)

Comprehensive in-vivo biomechanical study of IPPs yields interesting results (#241)

J.J. Wallen (USA)

Prosthetic sparing surgery: risk factors for infection and keys to success (#242)

J. Slongo (USA)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 8 - Sexual endocrinology 1

Location: Pavilion 5
Moderators: Serge Carrier (Canada) & Casey McCraw (USA)

The association of sex hormone binding globulin with mortality is mediated by age in men with type 2 diabetes (#243)

S. Ramachandran (United Kingdom)

Analysis of microbiome prostatic secretion in depending of levels total testosterone in blood serum (#244)

D.V. Krakhotkin (Russia)

Reference intervals for serum testosterone levels in Korean: results from large health examination data (#245)

M. Kim (Korea)

Serum testosterone profiles in men on testosterone therapy after bilateral orchiectomy (#246)

J. Torremade (USA)

Correlation between testosterone to estradiol ratio and score on the aging males’ symptom scale in late-onset hypogonadism (#247)

T. Suetomi (Japan)

Sexual dysfunction in men with pre-diabetes – results from a cross-sectional study (#248)

Eugenio Ventimiglia (Italy)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 9 - Female sexual function

Location: Pavilion 5
Moderators: Alexandre Kamnerdsiri (Belgium), Becky Lynn (USA) & Gideon Sartorius (Switzerland)

Midurethral sling placement disrupts periurethral neurovascular and glandular structures near anterior vaginal wall: Potential role in female sexual dysfunction (#249)

Johanna Hannan (USA)

Safety and efficacy of high intensity focused ultrasound treatment for vagina-3 months results- (#250)

Y. Sekiguchi (Japan)

FDA 510 K medical clearance for vaginal lubricants: issues and answers (#251)

Michael Krychman (USA)

Facing the transition changes in the puerperium. Couples experience (#252)

E. Gimeno (Spain)

Clitoral reconstruction/transposition after female genital mutilation/cutting: differences in access, refunding, technique, care and outcomes (#253)

J. Abdulcadir (Switzerland)

Vaginal stenosis prevention program: The evidence of practice (#254)

S. Russo (Portugal)


04:30 p.m. - 05:30 p.m.

Innovation platform (non CME)

Location: Auditorium I
Moderators: Maarten Albersen (Belgium) & Faysal Yafi (USA)

04:30 p.m. - 05:30 p.m.

Sex for procreation, effects on recreation

Location: Auditorium II
Moderators: Johannes Bitzer (Switzerland), Sidney Glina (Brazil) & Yiming Yuan (China)

04:30 p.m. - 04:45 p.m.

Evolutionary role of recreation during procreation

Emmanuele Jannini (Italy)

04:45 p.m. - 05:00 p.m.

Family planning and the effects on sexuality

Gideon Sartorius (Switzerland)

05:00 p.m. - 05:15 p.m.

Is there a role of sexual education in the infertile couple?

Eline Dancet (The Netherlands)

05:15 p.m. - 05:30 p.m.

The effect of infertility and infertility treatments on sex life and the couple

Francesca Tripodi (Italy)


04:30 p.m. - 05:30 p.m.

Measuring the sexual response in the lab

Location: Room 5 B/C in Pavilion 5
Moderators: Nelson Bennett (USA) & Gerald Brock (Canada)

04:30 p.m. - 04:45 p.m.

Implicit measures

Charmaine Borg (The Netherlands)

04:45 p.m. - 05:00 p.m.

Measuring sexual response in animal models

James Pfaus (Canada)

05:00 p.m. - 05:15 p.m.

Psychophysiological measures

Pedro Nobre (Portugal)

05:15 p.m. - 05:30 p.m.

Daily diary and experienced sampling methods

Kevan Wylie (United Kingdom)


04:30 p.m. - 05:30 p.m.

Workshop: Education in sexual medicine

Location: Auditorium III
Faculty: Yacov Reisman (The Netherlands) & Alan Shindel (USA)

05:30 p.m. - 06:30 p.m.

Keynote lecture

Location: Auditorium I
Moderators: Mikkel Fode (Denmark) & Wayne Hellstrom (USA)

How conventional thinking slows the future of sexual medicine

Tim Urban (USA)


Evening

06:30 p.m. - 07:30 p.m.

Opening ceremony

Location: Auditorium I

07:30 p.m. - 08:30 p.m.

Networking reception and official opening technical exhibition

Location: Pavilion 4

Friday, March 2, 2018

Morning

07:30 a.m. - 08:30 a.m.

ISSM business meeting (members only)

Location: Auditorium II

08:30 a.m. - 10:00 a.m.

Sexology, gender, psychosexual issues

Location: Auditorium I
Moderators: Stanley Althof (USA), Sandrine Atallah (Lebanon) & Kevan Wylie (United Kingdom)

08:30 a.m. - 08:50 a.m.

The neurobiology of sexual function

Tillmann Krueger (Switzerland)

08:50 a.m. - 09:10 a.m.

Should compulsive sexual behavior be considered an addiction?

Paula Hall (United Kingdom)

09:10 a.m. - 09:30 a.m.

Gender-affirming endocrine care of transgender people

Guy T'Sjoen (Belgium)

09:30 a.m. - 09:50 a.m.

Social media for the sexual medicine practicioner 2.0

Don Dizon (USA)

09:50 a.m. - 10:00 a.m.

Q&A/discussion


08:30 a.m. - 10:00 a.m.

Prosthetic / reconstructive session

Location: Auditorium II
Moderators: Bulent Alici (Turkey), Alejandro Carvajal (Colombia) & Giulio Garaffa (United Kingdom)

08:30 a.m. - 08:45 a.m.

Urethroplasty and implications on sexual dysfunction

Premsant Sangkum (Thailand)

08:45 a.m. - 09:00 a.m.

Cometic urology

Rafael Carrion (USA)

09:00 a.m. - 09:15 a.m.

IPP surgery - Does speed kill?

Juan Ignacio Martinez-Salamanca (Spain)

09:15 a.m. - 09:30 a.m.

10 points for prosthetic excellence

Paul Perito (USA)

09:30 a.m. - 09:45 a.m.

Workup and surgical management of Peyronie's Disease

Georgios Hatzichristodoulou (Germany)

09:45 a.m. - 10:00 a.m.

Options for reconstructive surgery for male urinary incontinence

Brian Christine (USA)


08:30 a.m. - 10:00 a.m.

Podium session 3 - Fertility and STI

Location: Room 5 B/C in Pavilion 5
Moderators: Marij Dinkelman-Smit (The Netherlands) & Edward Kim (USA)

Trans persons' ideas and concerns about fertility and fertility preservation: a population-based survey (#036)

J. Defreyne (Belgium)

Semen quality impairment is associated with sexual dysfunction according to its severity (#037)

F. Lotti (Italy)

Usefulness of a portable sperm analyzer system using smartphone (#038)

N.C. Park (Korea)

Y-chromosome abnormalities in men with sub-fertility. An analysis of the frequency of abnormalities and determination of a threshold sperm concentration for genetic analysis (#039)

M. Johnson (United Kingdom)

A UK multicentre study analysing the surgical sperm retrieval rates in men with non-mosaic Klinefelter's syndrome undergoing mTESE (#040)

M. Johnson (United Kingdom)

Serum metabolomic analysis identifies unique signatures in azoospermic men (#041)

Z. Zhang (China)

Testicular sperm for ICSI in men with high DFI - Can it be made a Recommendation? (#042)

A.K. Ponnusamy (India)

Testicular blood flow in varicocele patients and it’s correlation with semen quality (#043)

K. Ur Rehman (Pakistan)

Two testes are better than one: results of a large multicentric retrospective study on testis sparing surgery (#044)

G. Gentile (Italy)

The Fertility quality of life and Sexual dysfunction in men seeking fertility treatment  (#045)

Z. Zhang (China)

Hospital-based STIs prevalence and associated factors in transgender men from southern Brazil (#046)

A. Brandelli Costa (Brazil)

Relation of sexual behavior with extra-genital Candida colonization in women with recurrent Candida vulvo-vaginitis (RVVC). (#047)

S. Grinceviciene (Belgium)

Trends in gonorrhoea infection and overseas sexual contacts among females in Melbourne, Australia, 2008-2015 (#048)

E.P.F. Chow (Australia)

Preventing sexually transmitted infection from hookups in Taiwan (#049)

H.C. Chung (Taiwan)

Associations between HIV-status and sexual dysfunction in homosexual men – findings from the German male sex-study (#050)

S. Schneider-Wirth (Germany)


10:00 a.m. - 10:30 a.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

10:00 a.m. - 10:30 a.m.

Moderated poster tour 10 - ED: surgical therapy 2

Location: Pavilion 5
Moderators: Maxime Sempels (Belgium) & Ashley Tapscott (USA)

Prolonged closed suction drains lowered hematoma rates and facilitated early pump operation after inflatable penile prosthesis implantation (#255)

S.G. Song (USA)

Pelvic pain after inflatable penile prosthesis implantation persists despite revision or explantation (#256)

J.D. Campbell (USA)

Upsizing of penile prostheses in mechanical failure replacement (#257)

C. Ferreiro (Spain)

Sustainable longterm results in sexual function and activity after prostate cancer surgery, using a postoperative rehabilitation program with involvement of a clinical sexologist. A seven year follow-up (#258)

C. Ljunggren (Sweden)

Penile prosthesis implantation preserves penile length (#259)

S. Giona (United Kingdom)

Diabetes and level of fasting blood sugar has no relationship to the development of subsequent penile prosthesis infection in Korean men (#260)

S.H. Park (Korea)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 11 - Sexual desire

Location: Pavilion 5
Moderators: Charmaine Borg (The Netherlands), Anita Clayton (USA) & James Pfaus (Canada)

Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples (#261)

M.A. Ramezani (Iran)

Viewing time and penile plethysmography measurement in a group of admitting pedophiles (#262)

T. Wells (Czech Republic)

A qualitative exploration of the distress resulting from sexual desire difficulties in couples (#263)

R.N. Frost (Australia)

Model of integration of human sexuality (#264)

L. Mantecon-Garza (USA)

Hypossexuality in temporal lobe epilepsy (#265)

F.N. Novais Oliveira Cruz (Portugal)

The prevalence of sexual dysfunction and its related to personality traits in Arab women living in Saudi Arabia (#266)

A. Attaky (Saudi Arabia)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 12 - Sexual issues in cancer patients

Location: Pavilion 5
Moderators: Luca Incrocci (The Netherlands) & Sam Ward (Belgium)

OncoSexology clinic in Portugal (#267)

L. Monteiro (Portugal)

Bother associated with climacturia after radical prostatectomy: prevalence, degree and predictors (#268)

E.P. Miranda (USA)

Climacturia following radical prostatectomy: the time is now to query and treat (#269)

Casey McCraw (USA)

Sexual outcomes of gynecologic cancer survivors (#270)

Y.J. Chou (Taiwan)

Social deprivation trends in operative penile cancer (#271)

M.J. Rewhorn (United Kingdom)

Sexual dysfunctions after high dose rate brachytherapy for gynaecolofical cancer treatment (#272)

K.C. Bragante (Brazil)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 13 - Basic research 2

Location: Pavilion 5
Moderators: Nikolai Sopko (USA) & Emmanuel Weyne (Belgium)

Melatonin receptor-mediated ameliorative effect against erectile dysfunction in rats with streptozotocin-induced type 1 diabetes (#273)

Z. Tang (China)

Fetal programming by high-fat diet promoted prostatic atrophy in Wistar rats’ offspring (#274)

F. Sampaio (Brazil)

Inhibition of proNGF pathway restores erectile function by enhancing cavernous angiogenesis and neural regeneration in streptozotocin-induced diabetic mouse (#275)

J.K. Suh (Korea)

Adipose-derived stem cell-derived exosomes ameliorate erectile dysfunction in a rat model of type 2 diabetes (#276)

A. Wei (China)

Interplay between TNFa and TGF-B1 in a cell culture model of Peyronie’s Disease (#277)

U. Milenkovic (Belgium)

Melatonin treatment improved erectile dysfunction via inhibiting oxidative stress and apoptosis in a hyperhomocysteinemia rat model (#278)

Z. Tang (China)


10:30 a.m. - 11:00 a.m.

ESSM award of excellence

Location: Auditorium I
Moderator: Patrick Jern (Finland)

Ege Can Serefoglu (Turkey)


10:30 a.m. - 11:30 a.m.

Workshop: Treatment Requests and options within trans healthcare

Location: Auditorium III
Faculty: Alessandra Fisher (Italy) & Timo Nieder (Germany)

10:30 a.m. - 11:30 a.m.

Oncofertility

Location: Auditorium II
Moderators: Nelson Bennett (USA), Mai Ba Tien Dung (Vietnam) & Luca Incrocci (The Netherlands)

10:30 a.m. - 10:45 a.m.

Prepubertal fertility preservation

Jens Sonksen (Denmark)

10:45 a.m. - 11:00 a.m.

Fertility preservation in male cancer patients

Alexander Pastuszak (USA)

11:00 a.m. - 11:15 a.m.

Management of infertile men with testicular cancer: OncoTESE?

Edward Kim (USA)

11:15 a.m. - 11:30 a.m.

Hypogonadism in young cancer survivors

Alison Reid (United Kingdom)


10:30 a.m. - 12:30 p.m.

Podium session 4 - Penile surgery

Location: Room 5 B/C in Pavilion 5
Moderators: Brian Christine (USA), Fulvio Colombo (Italy) & Lawrence Hakim (USA)

“Andrianne mini-jupette” graft at the time of inflatable penile prosthesis placement for the management of post-prostatectomy climacturia and minimal urinary incontinence (#051)

Faysal Yafi (USA)

Effects of pan-pelvic endovascular intervention on erectile function: results of computed tomographic angiography and 12-month clinical follow-up from the all-comer PERFECT registry (#052)

T.D. Wang (Taiwan)

Emerging complications after ectopic placement of reservoirs during inflatable penile prosthesis surgery: a multi-institutional experience (#053)

J. Clavell Hernandez (USA)

Magnetic induction of novel shape memory alloy penile prosthesis (#054)

Kevin McVary (USA)

Prosthetic Urology Trends: 12-year analysis of inflatable penile prosthesis Implantation using patient information forms data from a single manufacturer (#055)

Laith Alzweri (USA)

Novel concept to enable an old idea: a flexible electrode array to recover neurogenic erectile dysfunction (#056)

M. Sturny (Switzerland)

Vacuum erection device before penile prosthesis implantation: a randomized controlled trial (#057)

O. Canguven (Qatar)

Quality of life after penile prosthesis implantation – 1-year follow-up data of the INSIST-ED national prospective registry (#058)

M. Silvani (Italy)

Local anaesthesia eluting property of Coloplast Titan penile prosthesis hydrophilic coating: An in-vitro drug elution profile and a randomised double-blind clinical outcome study (#059)

Eric Chung (Australia)

Cavernous tissue sparing penile prosthesis implantation; a pilot Study (#060)

A.A. Zaazaa (Egypt)

The male sub-urethral sling versus the artificial urinary sphincter for treatment of stress urinary incontinence (#061)

J. Dockray (United Kingdom)

A systematic review and network meta-analysis on the clinical efficacy of intralesional therapy for Peyronie’s Disease in controlled clinical trials (#062)

Giorgio Ivan Russo (Italy)

Multi-institutional prospective analysis of intralesional injection of collagenase clostridium histolyticum, tunical plication and partial plaque excision and grafting for the management of Peyronie’s Disease (#063)

Faysal Yafi (USA)

Novel nomogram predicting the probability of penile curvature improvement in patients Collagenase Clostridium Histolyticum (CCH-Xiapex®) using a new shortened protocol (#064)

Andrea Cocci (Italy)

Complication rate and satisfaction data of complex penile surgery in comparison with simple prosthetic surgery in a 395 patient monocentric series. The more complex is more dangerous? (#065)

C. Ceruti (Italy)

Pilot study to assess feasibility, safety and efficacy of penile splint device in the immediate postoperative management of grafting technique in Peyronie´s Disease (PD) surgery: prospective randomized study (#066)

E. Fernández-Pascual (Spain)

The extra-tunical grafting procedure for Peyronie's Disease hourglass and indent deformities (#067)

A.B. Reed-Maldonado (USA)

Does pre-operative penile ultrasound help with surgical planning in patients with Peyronie’s Disease and erectile dysfunction? (#068)

D.J. Hawksworth (USA)

Malignant priapism: when is a computed tomography scan indicated? (#069)

M. Johnson (United Kingdom)

Penile prosthesis placement in the setting of prolonged refractory ischemic priapism: a single institution experience (#070)

J. Slongo (USA)


11:00 a.m. - 11:30 a.m.

Special master lecture

Location: Auditorium I
Moderators: Shinichi Hisasue (Japan) & Ronald Lewis (USA)

11:00 a.m. - 11:30 a.m.

Reflections on 40 years of modern sexual medicine

Hartmut Porst (Germany)


11:30 a.m. - 12:30 p.m.

ICS symposium: Pelvic pain

Location: Auditorium I
Moderators: Alessandra Graziottin (Italy), Lior Lowenstein (Israel) & Yacov Reisman (The Netherlands)

11:30 a.m. - 11:55 a.m.

Prolapse and sexual function

Montserrat Espuna Pons (Spain)

11:55 a.m. - 12:20 p.m.

Overactive pelvic floor and its complaints

Petra Voorham - van der Zalm (The Netherlands)

12:20 p.m. - 12:30 p.m.

Q&A/discussion


11:30 a.m. - 12:30 p.m.

Workshop: ESWT: protocols, devices, tips and tricks

Location: Auditorium III
Faculty: Dimitrios Hatzichristou (Greece) & Yoram Vardi (Israel)

11:30 a.m. - 12:30 p.m.

Sponsored session (non CME)

Location: Auditorium II

Afternoon

12:30 p.m. - 02:00 p.m.

Lunch break

Location: Pavilion 4

12:45 p.m. - 01:45 p.m.

Sponsored lunch symposium (non-CME)

Location: Room 5 B/C in Pavilion 5

02:00 p.m. - 03:00 p.m.

Testosterone replacement therapy

Location: Auditorium II
Moderators: Mario Maggi (Italy), Abraham Morgentaler (USA) & Yoshikazu Sato (Japan)

02:00 p.m. - 02:15 p.m.

Medical implications of hypogonadism

Martin Miner (USA)

02:15 p.m. - 02:30 p.m.

Update of CV and prostate risks by TRT

Amy Guise (USA)

02:30 p.m. - 02:45 p.m.

TRT for the treatment of sexual symptoms

Giovanni Corona (Italy)

02:45 p.m. - 03:00 p.m.

TRT for the improvement of metabolism

Geoff Hackett (United Kingdom)


02:00 p.m. - 03:00 p.m.

Workshop: Practical management of sexual health issues in disabled people

Location: Auditorium III
Faculty: Woet Gianotten (The Netherlands) & Michal Lew-Starowicz (Poland)

02:00 p.m. - 04:00 p.m.

VJPU Session - Advanced prosthetic techniques (non-CME)

Location: Auditorium I
Moderator: Steven Wilson (USA)

02:00 p.m. - 02:10 p.m.

Insertion cylinders into scarred corporal bodies: Tunnel technique

Steven Wilson (USA)

02:10 p.m. - 02:20 p.m.

How to perform a revision IPP under local anesthesia

Sung Hun Park (Korea)

02:20 p.m. - 02:30 p.m.

Salvage of infected prosthesis with malleable

Rafael Carrion (USA)

02:30 p.m. - 02:40 p.m.

Impending cylinder erosion

David Ralph (United Kingdom)

02:40 p.m. - 02:50 p.m.

Peyronie’s Disease and ED: IPP & modeling

Ashley Tapscott (USA)

02:50 p.m. - 03:00 p.m.

Placement of AUS & Malleable through one incision

Rafael Carrion (USA)

03:00 p.m. - 03:10 p.m.

Peyronie’s Disease and ED: Plaque incision and Tachosil®

Daniar Osmonov (Germany)

03:10 p.m. - 03:20 p.m.

Sliding procedure for penile lengthening with IPP

David Ralph (United Kingdom)

03:20 p.m. - 03:30 p.m.

Complications of IPP cylinder and management

Ahmad Shamsodini (Qatar)

03:30 p.m. - 03:40 p.m.

Removal & replace AUS – Novel technique

Ryan Terlecki (USA)

03:40 p.m. - 03:50 p.m.

Trans corporal cuff placement of AUS

Andrew Kramer (USA)

03:50 p.m. - 04:00 p.m.

Double cuff AUS

Koenraad Van Renterghem (Belgium)


02:00 p.m. - 04:00 p.m.

Dyadic perspective on sexual responding

Location: Room 5 B/C in Pavilion 5
Moderators: Chris Nelson (USA), Patricia Pascoal (Portugal) & Francesca Tripodi (Italy)

02:00 p.m. - 02:20 p.m.

The role of psychological and relational dimensions in sexual functioning

Ana Luísa Quinta Gomes (Portugal)

02:20 p.m. - 02:40 p.m.

Predictors of sexual distress in women with desire and arousal difficulties: Distinguishing between biologic and psychologic issues

Irwin Goldstein (USA)

02:40 p.m. - 03:00 p.m.

Dyadic associations in perceived sexual desire between partners in established relationships

Stanley Althof (USA)

03:00 p.m. - 03:20 p.m.

Intimately connected: The importance of partner responsiveness for experiencing sexual desire

Chris Nelson (USA)

03:20 p.m. - 03:40 p.m.

Attachment and sexual functioning

Marieke Dewitte (Belgium)

03:40 p.m. - 04:00 p.m.

Q&A/discussion


03:00 p.m. - 04:00 p.m.

Male infertility, general health and sexual dysfunction

Location: Auditorium II
Moderators: Peter Chan (Canada) & Edward Kim (USA)

03:00 p.m. - 03:15 p.m.

Genetic factors

Dana Ohl (USA)

03:15 p.m. - 03:30 p.m.

Endocrine disruptors and male infertility

Christian Fuglesang (Denmark)

03:30 p.m. - 03:45 p.m.

Infertility is the mirror of general health

Andrea Salonia (Italy)

03:45 p.m. - 04:00 p.m.

The complex interplay between sexual dysfunction and infertility

Laith Alzweri (USA)


03:00 p.m. - 04:00 p.m.

Workshop: Medical treatment of female sexual dysfunction - Indications and limitations

Location: Auditorium III
Faculty: Annamaria Giraldi (Denmark) & Gideon Sartorius (Switzerland)

04:00 p.m. - 04:30 p.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

04:00 p.m. - 04:30 p.m.

Moderated poster tour 14 - Sex and relationship therapy

Location: Pavilion 5
Moderators: Stacy Elliott (Canada) & Evie Kirana (Greece)

What are the factors influencing the length of the successful therapy of unconsummated marriages? (#279)

S. Jakima (Poland)

The association of body dissatisfaction with sexual distress in pregnant and non pregnant women: testing a mediation model (#280)

S. Coelho (Portugal)

Long-term effectiveness of successful therapy of primary unconsummated marriages (#281)

S. Jakima (Poland)

Pillow talk – Female partner the key factor in men´s sexual dysfunction rehabilitation (#282)

C. Rocha Silva (Portugal)

Working with a group of young women affected by androgen insensitivity syndrome (#283)

M. Di Grazia (Italy)

The Portuguese versions of the women’s and men’s sexual self-schema scales: validity and reliability psychometric properties (#284)

Pedro Nobre (Portugal)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 15 - ED: medical therapy 1

Location: Pavilion 5
Moderators: Rafael Carrion (USA) & Natalio Cruz Navarro (Spain)

Development of an evidence-based protocol for the application of low-intensity shockwave therapy for erectile dysfunction: comparison of two treatment protocols and the impact of repeating treatment (#285)

Dimitrios Hatzichristou (Greece)

Efficacy of autologous platelet-rich plasma for the treatment of erectile dysfunction (#286)

M.V. Epifanova (Russia)

Intracavernous prostaglandin injection might be a good method to evaluate objectively the response to LISWT and to predict the number of LISWT sessions needed in ED patients (#287)

Jawad Feghali (Lebanon)

The role of low-intensity shock wave therapy on erectile dysfunction (#288)

P. Simoes de Oliveira (Portugal)

Prevalence of target organ damage in the arterial system of men with erectile dysfunction: diagnostic definition according to recommendations of the European Society of Cardiology and American Heart Association (#289)

S. Cedres (Uruguay)

Efficacy of low-intensity shock wave therapy for the treatment of ED in diabetic patients : a Pooled analysis (#290)

L. Spivak (Russia)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 16 - ED: diagnosis

Location: Pavilion 5
Moderators: Yoshikazu Sato (Japan) & Eugenio Ventimiglia (Italy)

Gray-scale ultrasound to assess persistent erectile dysfunction in young men (#291)

Irwin Goldstein (USA)

The effect of real-time erectile rigidity tested by Rigiscan on diagnosis of erectile dysfunction (#292)

J. Peng (China)

Usefulness of RigiScan® evaluation of nocturnal penile tumescence (#293)

Koichi Nagao (Japan)

Erectile dysfunction associates own "arterial phenotype" defined by greater atherosclerotic burden, arterial stiffness and thickness and vascular reactivity lower than expected from exposure to risk factors (#294)

S. Cedres (Uruguay)

The implication of aortic calcification on severe erectile dysfunction in patients with end stage renal disease (#295)

N. Fujita (Japan)

The organic erectile dysfunction associates premature arterial aging higher than the already expected because of the exposure to the traditional cardiovascular risk factors (#296)

S. Cedres (Uruguay)


04:00 p.m. - 04:30 p.m.

Moderated poster tour 17 - Sexual endocrinology 2

Location: Pavilion 5
Moderators: Giulia Rastrelli (Italy) & Landon Trost (USA)

Effects of hypothyroidism on lower urinary tract symptoms, testosterone and sexual function in men (#297)

S.U. Jeh (Korea)

Testosterone and cardiovascular risk: meta-analysis of observational and interventional studies (#298)

Giulia Rastrelli (Italy)

Which patients with non-symptomatic late onset hypogonadism are suitable for testosterone replacement therapy? (#299)

H.J. Park (Korea)

RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration (#300)

O. Canguven (Qatar)

Do doctors treating menopausal women and andropausal men talk about sexual health in patient-treatment? Igls-SexMed-Survey-Program, doctors' self-assessment results at the Vienna Congress for Meno-/Andropause, Anti-Ageing, December 2017, Vienna (#301)

L. Ucsnik (Austria)

Stimulating hormone therapy in the treatment of age related hypogonadism (#302)

M. Boiko (Ukraine)


04:30 p.m. - 05:30 p.m.

Best of JSM 2017

Location: Auditorium I
Moderator: John Mulhall (USA)

Annamaria Giraldi (Denmark), John Mulhall (USA) & Andrea Salonia (Italy)


04:30 p.m. - 05:30 p.m.

Translational research in sexual medicine: Are we getting forward?

Location: Auditorium II
Moderators: Ganesh Adaikan (Singapore), Carla Sofia Costa (Portugal) & Zhong-Cheng Xin (China)

04:30 p.m. - 04:45 p.m.

Animal models

Johanna Hannan (USA)

04:45 p.m. - 05:00 p.m.

Stem cell research

Fabio Castiglione (Italy)

05:00 p.m. - 05:15 p.m.

Tissue engineering in sexual medicine & urology

Ryan Terlecki (USA)

05:15 p.m. - 05:30 p.m.

Translational pharmacotherapy

Michael DiSanto (USA)


04:30 p.m. - 05:30 p.m.

Podium session 5 - Medical management male sexual dysfunction

Location: Room 5 B/C in Pavilion 5
Moderators: Juan Fernando Uribe Arcila (Colombia) & Faysal Yafi (USA)

The impact of androgen deprivation therapy on compliance with intracavernous injections (#071)

J. Torremade (USA)

Preservation of baseline erectile function in radiotherapy patients using PDE5i (#072)

E.P. Miranda (USA)

Over-the-counter use of PDE-5 inhibitors – focus on safety issues (#073)

Michal Lew-Starowicz (Poland)

Tadalafil 5mg on alternate days for treatment of erectile dysfunction (#074)

J. Borges Cabral Junior (Brazil)

How important is the preservation of nocturnal penile tumescense with daily low-dose sildenafil 6 weeks after nerve-sparing radical prostatectomy for the erectile function after 2 years? - Penile rehabilitation in the long term follow-up (#075)

A. Bannowsky (Germany)

Sexual dynamics as a critical part in the individualised management of men with erectile dysfunction in UK (#076)

T.A. Hassan (USA)

A randomized, controlled, three-arm study to define the utility of PDE5 inhibitors and intracavernosal injections in the radical prostatectomy population (#077)

E.P. Miranda (USA)

Amniotic fluid allograft for the treatment of erectile dysfunction: a pilot series (#078)

J. Slongo (USA)

Low-intensity shockwave therapy for erectile dysfunction: the effect of energy flux density level and frequency of sessions per week (#079)

Dimitrios Hatzichristou (Greece)

Comparison of two low-intensity ESWT protocols in patients with erectile dysfunction (#080)

J.P. Saffon (Colombia)


04:30 p.m. - 05:30 p.m.

Workshop: Vulvoscopy + female clinical investigation

Location: Auditorium III
Faculty: Leen Aerts (Switzerland) & Irwin Goldstein (USA)

05:30 p.m. - 06:30 p.m.

Priapism update

Location: Auditorium I
Moderators: Giorgio Bozzini (Italy), Gregory Broderick (USA) & Fernando Facio (Brazil)

05:30 p.m. - 05:45 p.m.

Treatment options for stuttering priapism

Arthur Burnett (USA)

05:45 p.m. - 06:00 p.m.

Treatment options for high-flow priapism

Lawrence Jenkins (USA)

06:00 p.m. - 06:15 p.m.

Debate: What to do at 36 hours in ischemic priapism? - Immediate implantation of IPP is the way to go

Marco Capece (Italy)

06:15 p.m. - 06:30 p.m.

Debate: What to do at 36 hours in ischemic priapism? - Con: Delayed placement

Trinity Bivalacqua (USA)


05:30 p.m. - 06:30 p.m.

Vulvar and vaginal applications of optic and radiofrequent energy

Location: Auditorium II
Moderators: Sue Goldstein (USA), Alessandra Graziottin (Italy) & Pedro Vieira Baptista (Portugal)

05:30 p.m. - 05:50 p.m.

Laser therapy for the restoration of vaginal function

Becky Lynn (USA)

05:50 p.m. - 06:10 p.m.

Surface-cooled radiofrequency therapy on vaginal laxity and female sexual function

Michael Krychman (USA)

06:10 p.m. - 06:30 p.m.

A critical interpretation of the level of evidence supporting vaginal laser and RFA application

Hana Yoon (Korea)


05:30 p.m. - 06:30 p.m.

Workshop: Sperm retrieval and advanced processing techniques for assisted reproduction: Tricks of the trade

Location: Auditorium III
Faculty: Peter Chan (Canada) & Suks Minhas (United Kingdom)

05:30 p.m. - 06:30 p.m.

Podium session 6 - Androgens and sexual endocrinology

Location: Room 5 B/C in Pavilion 5
Moderators: Mohit Khera (USA) & Adrian Momesso (Argentina)

Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial (#081)

Giulia Rastrelli (Italy)

Testosterone replacement therapy may upregulate pro-erectile markers by modulating endothelial function In hypogonadal men with erectile dysfunction (#082)

Laith Alzweri (USA)

Does concomitant testosterone replacement improve the response of tadalafil 5 mg once daily in men with lower urinary tract symptoms? (#083)

H.J. Park (Korea)

Sex hormone binding globulin is associated with androgen deficiency features independently of total testosterone (#084)

Giulia Rastrelli (Italy)

Low PSA level in men diagnosed with prostate cancer predicts testosterone deficiency (TD) (#085)

H. Bernie (USA)

Testosterone recovery profiles after cessation of androgen deprivation therapy (ADT) (#086)

John Mulhall (USA)

Predictive factors for maintenance of efficacy after cessation of testosterone treatment (#087)

M.G. Park (Korea)

Influence of genotype and hyperandrogenism on sexual function, gender role and sexual preference in 35 females with congenital adrenal hyperplasia (#088)

M. Bayerle-Eder (Austria)

Failure of testosterone replacement therapy to improve symptoms correlates with burden of systemic conditions (#089)

D. Shoskes (USA)

Reduction of major adverse cardiovascular events (MACE) and improvement of erectile function in hypogonadal men receiving testosterone therapy – real-life evidence from a registry study (#090)

K.S. Haider (Germany)


Saturday, March 3, 2018

Morning

08:30 a.m. - 10:00 a.m.

Female sexual dysfunction

Location: Auditorium II
Moderators: Woet Gianotten (The Netherlands), Annamaria Giraldi (Denmark) & Irwin Goldstein (USA)

08:30 a.m. - 08:50 a.m.

Psychological and physiological characteristics of female desire and arousal

Linda Vignozzi (Italy)

08:50 a.m. - 09:10 a.m.

Sexuality in female cancer patients

Alessandra Graziottin (Italy)

09:10 a.m. - 09:30 a.m.

Future treatment targets for female sexual dysfunction

Melissa Farmer (USA)

09:30 a.m. - 09:50 a.m.

HSDD consensus

Anita Clayton (USA)

09:50 a.m. - 10:00 a.m.

Q&A/discussion


08:30 a.m. - 10:00 a.m.

SMSNA session

Location: Auditorium III
Moderators: Wayne Hellstrom (USA) & John Mulhall (USA)

08:30 a.m. - 08:45 a.m.

Trends in sexual medicine: U.S. headlines

Gregory Broderick (USA)

08:45 a.m. - 09:00 a.m.

Controversies in testosterone therapy – What we learned from the T trials

Mohit Khera (USA)

09:00 a.m. - 09:15 a.m.

Alternatives to testosterone therapy

Nelson Bennett (USA)

09:15 a.m. - 09:30 a.m.

The reluctant reservoir – technical considerations in IPP reservoir removal

Hossein Sadeghi-Nejad (USA)

09:30 a.m. - 09:45 a.m.

Current medical therapies for Peyronies Disease

Lawrence Hakim (USA)

09:45 a.m. - 10:00 a.m.

Surgical techniques: Size restoration for Peyronie’s Disease without penile degloving

Run Wang (USA)


08:30 a.m. - 10:00 a.m.

Podium session 7 - Male sexual dysfunction from diagnosis to therapy

Location: Room 5 B/C in Pavilion 5
Moderators: Marco Capece (Italy) & Alejandro Carvajal (Colombia)

Can we predict patients’ compliance to PDE5 inhibitors at baseline assessment? (#091)

Eugenio Ventimiglia (Italy)

Impact of PDE5 inhibitor (PDE5i) use on biochemical recurrence rates in prostate cancers patients following radiotherapy (RT) (#092)

E.P. Miranda (USA)

The predictor of low-intensity extracorporeal shockwave therapy to convert non-responder to responder of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction (#093)

C.C. Liu (Taiwan)

Evaluation of the outcome of penile implants surgery In seniors (#094)

M. Habous (Saudi Arabia)

Aberrant functional coherence of the right anterior insular in psychogenic erectile dysfunction patients: a resting state MRI study (#095)

M. Dong (China)

Smart SAA- sex smart in a click (#096)

P.E.S. Schartau (United Kingdom)

In obese hypogonadal men, long-term testosterone therapy improves erectile function, quality of life and body weight – real-life evidence from a registry study (#097)

A. Haider (Germany)

Sexual life satisfaction related to erectile function across different ages (#098)

W. Cazzaniga (Italy)

Erectile function improves in hypogonadal men with type 2 diabetes under long-term testosterone therapy: real-world evidence from a urological registry study (#099)

F. Saad (Germany)

Avanafil 200 mg vs Sildenafil 100 mg post nerve sparing robotic prostatectomy: a multicentric prospective randomized trial (#100)

P.A. Della Camera (Italy)

A randomised controlled study evaluating sildenafil-pentoxifylline combination therapy in the management of erectile dysfunction (#102)

Y.X.T. Law (Singapore)

A novel technique treating BPH while preserving sexual functions: Urolift (#103)

S.T. Ahn (Korea)

Erectile dysfunction associated to decrease in sleep quality in young adults of a 51vian university (#104)

L.A. Grandez-Urbina (Peru)

Comparison of short-term urinary incontinence and erectile dysfunction after open, laparoscopic or robotic assisted radical prostatectomy (#105)

Xiaodong Jin (China)


08:30 a.m. - 10:00 a.m.

Podium Session 8 - Psychosocial considerations in "normal" to problematic sexual behaviour

Location: Auditorium IV
Moderators: Stanley Althof (USA), Evie Kirana (Greece) & Michal Lew-Starowicz (Poland)

Testing a psychosocial model of male sexual desire (#106)

F.M. Nimbi (Italy)

Individual and relational correlates of sexual satisfaction in a clinical sample with sexual complaints: a cross-sectional study with cisgendered heterosexual adults in a monogamous relationship (#107)

Patricia Pascoal (Portugal)

Psychosocial predictors of male sexual desire (#108)

F.M. Nimbi (Italy)

The development and psychometric properties of the sexual and relationship distress scale (SaRDS) (#109)

R.N. Frost (Australia)

Factors associated with declining to report the number of sexual partners using computer-assisted self-interviewing: a cross-sectional study among individuals attending a sexual health service in Melbourne, Australia (#110)

E.P.F. Chow (Australia)

Association of low sexual desire with current sexual behavior, self-concept as well as comorbidities and lifestyle factors (#111)

V. Goethe (Germany)

The impact of expression of feelings on sexual satisfaction: testing the mediating role of sexual self-disclosure in a sample of cisgendered heterosexual adults in a monogamous relationship (#112)

Patricia Pascoal (Portugal)

Sexual desire, alexithymia, interoception, and heart rate variability (#113)

R.M. Costa (Portugal)

A network approach to hypersexuality: insights and clinical implications (#114)

M. Werner (The Netherlands)

Obsessive-compulsive disorder in hypersexual patients (#115)

M. Smas-Myszczyszyn (Poland)

Approach and avoidance tendencies towards pornographic stimuli in hypersexual disorder (#116)

M. Veit (Germany)

Cyber pornography use inventory-9: factor structure and psychometric properties in the Portuguese population (#117)

J. Cardoso (Portugal)

Amateur home porno: same old risks for a new sexual practice (#118)

J.M. Poyato Galan (Spain)

Reward processing – related orbitofrontal reactivity alterations in patients suffering from problematic pornography use (#119)

Michal Lew-Starowicz (Poland)


09:00 a.m. - 11:00 a.m.

Sponsored session (non CME)

Location: Room 5 A in Pavilion 5

10:00 a.m. - 10:30 a.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

10:00 a.m. - 10:30 a.m.

Moderated poster tour 18 - Sexual arousal and its associated problems

Location: Pavilion 5
Moderators: Stanley Althof (USA), Heather Blaylock (South Africa) & Augusto José Pepe Cardoso (Portugal)

Altered brain networks in psychogenic erectile dysfunction a resting-state fMRI study (#303)

J. Chen (China)

Disrupted rich club and robustness of brain network in erectile dysfunction patients owing predominantly to psychological factors a structural and functional neuroimaging study (#304)

J. Chen (China)

Preferences for non-consensual sexual activities in the general population of Czech males (a representative survey) (#305)

R. Androvicova (Czech Republic)

Is stranger rape a strategy to avoid female courtship behavior?: a parallel fMRI and penile plethysmography study (#306)

R. Androvicova (Czech Republic)

Impaired prefrontal-amygdala pathway, self-reported emotion and erection in psychogenic erectile dysfunction patients with normal nocturnal erection (#307)

J. Chen (China)

Brain structural network topological alterations of the left prefrontal and limbic cortex in psychogenic erectile dysfunction (#308)

J. Chen (China)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 19 - Psycho-socio-cultural aspects of sexuality

Location: Pavilion 5
Moderator: Brynjar Landmark (Norway)

Psychological features, quality of life and sexual functioning in a group of adolescents and young adults living with a bladder exstrophy epispadias complex (#309)

M. Di Grazia (Italy)

Sexual functioning of women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome and its predictors (#310)

P. Weijenborg (The Netherlands)

Patients’ feelings of anger and shame are associated with gender role conflicts in conversations about sexuality during hospital stay (#311)

N. Komlenac (Austria)

Personality and psychosexual correlates of sexual and emotional responses to rape: a pupillometric study with community men (#312)

J. Carvalho (Portugal)

Modes, sexual beliefs, and cognitive schemas as important risk factors for male and female sexual dysfunctions: results from the Italian validation study of SMQ, SBDQ, and QCSASC (#313)

F.M. Nimbi (Italy)

Gender differences in pornography consumption: a representative study in the Slovak Republic (#314)

L. Krejcova (Czech Republic)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 20 - ED: medical therapy 2

Location: Pavilion 5
Moderators: Edouard Amar (France), Hui Jiang (China) & Giorgio Ivan Russo (Italy)

Clinical experience of shock waves therapy in the treatment of erectile dysfunction (#315)

J. Justo Quintas (Spain)

Low intensity shock wave tissue coverage for management of Erectile Dysfunction patients: preliminary comparative study (#316)

A. Abou Taleb (Egypt)

Effectiveness and safety of orodispersible Sildenafil in a new film formulation for the treatment of erectile dysfunction: comparison between Sildenafil 100 mg film-coated tablet (FCT) vs 75 mg orodispersible film (ODF) (#317)

Andrea Cocci (Italy)

Frequency of priapism and characterization of its management in patients with erectile dysfunction treatment (#318)

J.P. Saffon (Colombia)

Penile vibratory stimulation in penile rehabilitation after radical prostatectomy: a randomized, controlled trial (#319)

J. Clavell Hernandez (USA)

Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction (#320)

S. Alkhayal (United Arab Emirates)


10:00 a.m. - 10:30 a.m.

Moderated poster tour 21 - Basic research 3

Location: Pavilion 5
Moderators: Saleh BinSaleh (Saudi Arabia) & Nikolai Sopko (USA)

Pericytes in the corpora cavernosa has relationship with endothelial function in hyperlipidemia-associated ED mice (#321)

Y. Zhang (China)

Stromal derived factor-1 treatment results in stem cell pathway activation in penile tissues and increased neurotrophins in major pelvic ganglion (#323)

Nikolai Sopko (USA)

Characterization and functional roles of Kv7 Channels in corpus cavernosum smooth muscle (#324)

J.D. Chung (Korea)

Preserved erectile function in the hyperhomocysteinaemia transgenic rats harboring human tissue kallikrein 1 (#325)

J.H. Liu (China)

Protective effect of apelin-13 against hypercholesterolemia-induced fibrosis of the corpus cavernosum (#326)

M. Sturny (Switzerland)


10:30 a.m. - 11:30 a.m.

ESWT for ED, from basic research to implementation

Location: Auditorium III
Moderators: Dimitrios Hatzichristou (Greece), Pedro Vendeira (Portugal) & Run Wang (USA)

10:30 a.m. - 10:45 a.m.

Basic research background on the effects of ESWT: Angiogenesis and endogenous stem cells?

Tom Lue (USA)

10:45 a.m. - 11:00 a.m.

Point-counterpoint: ESWT for ED, ready for routine practice? - Pro

Ilan Gruenwald (Israel)

11:00 a.m. - 11:15 a.m.

Point-counterpoint: ESWT for ED, ready for routine practice? - Con

Landon Trost (USA)

11:15 a.m. - 11:30 a.m.

Discussion and rebuttal


10:30 a.m. - 11:30 a.m.

Workshop: Penile doppler ultrasound

Location: Auditorium IV
Faculty: Gregory Broderick (USA) & Suresh Sikka (USA)

10:30 a.m. - 12:30 p.m.

Nature doesn’t draw the line… session in collaboration with EPATH

Location: Auditorium II
Moderators: Nina Callens (Belgium), John Dean (United Kingdom) & Mona Reda (Egypt)

10:30 a.m. - 10:50 a.m.

Non-binary genders: Past-present-future

Timo Nieder (Germany)

10:50 a.m. - 11:10 a.m.

Being non-binary trans in Europe: Treatment experiences and requests

Joz Motmans (Belgium)

11:10 a.m. - 11:30 a.m.

Being non-binary trans in the UK: Data from a specialized centre

Walter Bouman (United Kingdom)

11:30 a.m. - 11:45 a.m.

DSD - The role of the mental health professional

Tim van de Grift (The Netherlands)

11:45 a.m. - 12:00 p.m.

DSD - The role of the endocrinologist

Syed Faisal Ahmed (United Kingdom)

12:00 p.m. - 12:15 p.m.

DSD - The role of the surgeon

Ronald Lewis (USA)

12:15 p.m. - 12:30 p.m.

DSD - The patient’s viewpoint – what should be done better?

Kitty Anderson (Iceland)


10:30 a.m. - 12:30 p.m.

Video abstracts

Location: Room 5 B/C in Pavilion 5
Moderators: Andrea Cocci (Italy), Giulio Garaffa (United Kingdom) & Andre Vandermerwe (South Africa)

Successful cosmetic reduction corporoplasty and scrotoplasty in a patient with the complaint of self-perceived too large penis and scrotum (#120)

Maxime Sempels (Belgium)

3D video assisted telescopic microsurgical subinguinal varicocelectomy (#121)

A. Gudeloglu (Turkey)

How to do a circumcision, when the foreskin is welded to the glans. The ROLOCS (Restoration Of the Lost Obscured Coronal Sulcus) procedure (#122)

P. Malone (United Kingdom)

Penile sclerosing granuloma – surgical excision (#123)

G. Blecher (United Kingdom)

Use of bilateral pedicled scrotal flaps to restore penile shaft defects: technic and results (#124)

J.E. Terrier (France)

Bladder exstrophy radial artery phalloplasty: exstrophy related issues and saphenous vein interposition graft (#125)

G. Chiriaco (United Kingdom)

Initial experience with the rapideclamp device in adult circumcision. Step-by-step surgical video (#126)

R. Garcia-Baquero (Spain)

Pericardial matrix for cavernous grafting: an effective procedure for increasing the penile girth (#127)

Fulvio Colombo (Italy)

Surgical management of severe post-operative skin necrosis after penile lengthening corporoplasty (#128)

Fulvio Colombo (Italy)

Endourological management of the obstruction of the ejaculatory ducts due to a midline prostatic cyst (#129)

L. Pujol (Spain)

Surgical technique for complex cases of Peyronie’s disease: penile prosthesis implantation, modified neurovascular bundle release and single or multiple corporeal incisions and grafting with collagen fleece (#130)

E. Fernández-Pascual (Spain)

Shaeer's corporal rotation III, modification of the original technique. Shaeer IV, a new twist (#131)

R. Garcia-Baquero (Spain)

Corporoplasty with ossified plaque excision and surgisis graft (#132)

C. Ferreiro (Spain)

Severe penile curvature correction with autologous foreskin graft (#133)

C. Lahoz Garcia (Spain)

A Multi-center analysis on surgical technique, outcomes and learning curve of male-to-female penoscrotal vaginoplasty (#134)

Andrea Cocci (Italy)


11:30 a.m. - 12:30 p.m.

Intralesional therapy for Peyronie’s Disease

Location: Auditorium III
Moderators: Antoine Faix (France), Ashley Tapscott (USA) & João Nuno Tomada (Portugal)

11:30 a.m. - 11:45 a.m.

Oral and systemic therapy in the acute phase: What’s the evidence?

Faysal Yafi (USA)

11:45 a.m. - 12:00 p.m.

What are our options in intralesional therapy?

Markus Margreiter (Austria)

12:00 p.m. - 12:15 p.m.

Point-counterpoint: Intralesional therapy for Peyronie's Disease is a game changer - Pro

Amr Raheem (United Kingdom)

12:15 p.m. - 12:30 p.m.

Point-counterpoint: Intralesional therapy for Peyronie's Disease is a game changer - Con

Amy Guise (USA)


11:30 a.m. - 12:30 p.m.

Workshop: Contemporary management of post-prostatectomy sexual dysfunction: From penile rehabilitation toward a global sexual assessment

Location: Auditorium IV
Faculty: Mikkel Fode (Denmark) & Pedro Vendeira (Portugal)

Afternoon

12:30 p.m. - 01:00 p.m.

Moderated poster tour 22 - Sexual and genital pain

Location: Pavilion 5
Moderators: Marieke Dewitte (Belgium) & Melissa Farmer (USA)

Validation of the chronic orchialgia symptom index for symptom severity and responsiveness to therapy (#327)

D. Shoskes (USA)

Scrotoscopy with a novel percutaneous endoscopy equipment to treat chronic idiopathic testicular pain: a single-center, prospective, clinical trial (#328)

X.J. Su (China)

Case series of low intensity shock wave therapy for men with chronic prostatitis/chronic pelvic pain syndrome (#329)

D. Shoskes (USA)

Patient acceptability of botulinum toxin injections for treatment of genito-pelvic pain/penetration disorder (#330)

E. Rudolph (South Africa)

Does genital sexual pain matter? An explorative study on reproductive-age women (#331)

V. Rossi (Italy)

Management and outcomes of penile fracture: a ten year multicentric study (#332)

N. Kara (France)


12:30 p.m. - 01:00 p.m.

Moderated poster tour 23 - ED: surgical therapy 3

Location: Pavilion 5
Moderators: Laith Alzweri (USA) & Hossein Sadeghi-Nejad (USA)

Inflatable penile prosthesis surgery can be performed safely and with good patient acceptance under local anesthesia in a free-standing clinic (#333)

S.H. Park (Korea)

Intraoperative management algorithm for urethral injury at the time of PP placement (#334)

J. Slongo (USA)

Preoperative administration of a long-acting local anesthetic block to limit narcotic use after inflatable penile prosthesis insertion (#335)

J. Rothwax (USA)

Glansectomy with neoglans construction surgery step by step (#336)

R. Ramos (Portugal)

Assessing the impact of male pelvic mesh surgery on male sexual function: Clinical evaluation of erectile, ejaculation and orgasm functions in men who underwent AdVance male sling surgery (#337)

Eric Chung (Australia)

Reduction corporoplasty after inflatable penile prosthesis revision failure (#338)

E. Rajih (Saudi Arabia)


12:30 p.m. - 01:00 p.m.

Moderated poster tour 24 - Fertility

Location: Pavilion 5
Moderators: Marco Capece (Italy) & Amr Raheem (United Kingdom)

Role of leptin and the leptin receptor in the pathogenesis of varicocele-induced testicular dysfunction (#339)

M. Gong (China)

Relationship between undescended testis position and prevalence of testicular appendices, epididymal anomalies and patency of processus vaginalis (#340)

F. Sampaio (Brazil)

The impact on fertility of bilateral and left varicocelectomy in infertile men with left clinical and right infra-clinical varicoceles: a comparative study (#341)

Y. Ouanes (Tunisia)

A web-based interactive sex-education program versus expectant management for couples with unexplained subfertility and a good prognosis: protocol for randomized controlled trial (#342)

F. Dreischor (The Netherlands)

Hypogonadism post TESE: how much is it really worrying? (#343)

A. Sacca (Italy)

Human spermatozoa function is positively influenced by Vitamin D (#344)

C. Gallo (Brazil)


12:30 p.m. - 01:30 p.m.

Lunch break and poster tours

Location: Pavilion 4 and 5

01:30 p.m. - 02:30 p.m.

Point-counterpoint: Penile length restoration: does it work?

Location: Auditorium II
Moderators: Paulo Egydio (Brazil) & João Nuno Tomada (Portugal)

01:30 p.m. - 01:45 p.m.

Debate: Division of dorsal ligament and adjunctive prepubic procedures - Yes

Giulio Garaffa (United Kingdom)

01:45 p.m. - 02:00 p.m.

Debate: Division of dorsal ligament and adjunctive prepubic procedures - No

Carlo Bettocchi (Italy)

02:00 p.m. - 02:15 p.m.

Debate: Sliding technique - Yes

Salvatore Sansalone (Italy)

02:15 p.m. - 02:30 p.m.

Debate: Sliding technique - No

Nim Christopher (United Kingdom)


01:30 p.m. - 02:30 p.m.

Female sexual function is sensory function?

Location: Auditorium III
Moderators: Melissa Farmer (USA), Arik Shechter (Israel) & Chiara Simonelli (Italy)

01:30 p.m. - 01:50 p.m.

Evidence-based vulvodynia assessment

Mijal Luria (Israel)

01:50 p.m. - 02:10 p.m.

Value of quantitative sensory testing in the evaluation of genital sensation: Its application to female sexual dysfunction

Lior Lowenstein (Israel)

02:10 p.m. - 02:30 p.m.

IUGA Lecture: Physical therapy in the treatment of central pain mechanisms for female sexual pain

Bary Berghmans (The Netherlands)


01:30 p.m. - 02:30 p.m.

Podium session 9 - Premature ejaculation

Location: Room 5 B/C in Pavilion 5
Moderators: Mai Ba Tien Dung (Vietnam) & Zhong-Cheng Xin (China)

A novel therapy for premature ejaculation: transcutaneous functional electrical stimulation-results of a pioneer study (#135)

Arik Shechter (Israel)

Setting of a scoring criterion for effectiveness index in patients with premature ejaculation (#136)

L. Hongjun (China)

Premature ejaculation: prevalence and association with lifestyle and psychosocial factors of 45-year old heterosexual men in Germany results of the German male sex-study (#137)

K. Herkommer (Germany)

Correlation of changes in IELT and indices of sexual satisfaction in PE patients (#138)

M.G. Wyllie (United Kingdom)

Evidence of correlation of PE patient and partner responses to effective therapy (#139)

M. Wyllie (United Kingdom)

Comparison of the effects and side effects between PDE-5 inhibitors combined with dapoxetine and single PDE-5 inhibitor for patients with premature ejaculation comorbid erectile dysfunction (#140)

J. Peng (China)

A randomized controlled trial of a new cognitive behavioral treatment in premature ejaculation: Sphincter control training with masturbation aid device (#141)

J.E. Rodríguez Martínez (Spain)

Efficacy and safety of traditional Chinese medicine Qiaoshao Formula combined with Dapoxetine in the treatment of premature ejaculation in Chinese men: a real-world study (#142)

J. Guo (China)

Effectiveness of Dapoxetine combined with Tamsulosin in the treatment of premature ejaculation secondary to category IIIB chronic prostatitis: a multicenter clinical study (#143)

Z. Li (China)

Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial (#144)

A. Abdelhamed (Egypt)


01:30 p.m. - 02:30 p.m.

Workshop: Managing female sexual pain in the practical setting: What makes a treatment plan successful?

Location: Auditorium IV
Faculty: Marieke Dewitte (Belgium) & Francesca Tripodi (Italy)

02:30 p.m. - 03:30 p.m.

Sexual health and the prostate

Location: Auditorium II
Moderators: Hui Jiang (China), Daniar Osmonov (Germany) & Luiz Otavio Torres (Brazil)

02:30 p.m. - 02:45 p.m.

Prostatitis, chronic pelvic pain and male sexual dysfunction: What is the common denominator?

Amr El-Meliegy (Egypt)

02:45 p.m. - 03:00 p.m.

The complex interplay between LUTS, ED and aging

Kevin McVary (USA)

03:00 p.m. - 03:15 p.m.

Tips and tricks to overcome sexual dysfunction in LUTS-BPH management

Paolo Verze (Italy)

03:15 p.m. - 03:30 p.m.

Have we finally determined an evidence based penile rehabilitation protocol post-prostatectomy?

Giorgio Gandaglia (Italy)


02:30 p.m. - 03:30 p.m.

Workshop: Prevention of complications during IPP placement

Location: Auditorium IV
Faculty: Amy Guise (USA) & Javier Romero-Otero (Spain)

02:30 p.m. - 03:30 p.m.

Podium session 10 - Miscellaneous

Location: Auditorium III
Moderators: Abdulaziz Baazeem (Saudi Arabia), Béatrice Cuzin (France) & Ira Sharlip (USA)

Exploratory cluster analysis of US males 40-70 years old focused on erectile dysfunction and associated risk factors, using National Health and Wellness Survey data (#145)

Irwin Goldstein (USA)

Effects of depression status on penile hemodynamics in men with erectile dysfunction (#146)

Y. Huang (China)

Effects of adult male circumcision on self-estimated intravaginal ejaculatory latency time and patient reported outcome measures (#147)

J. Gao (China)

Sexual dysfunction after breast cancer patients after diagnosis and treatment (#148)

H. Salem (Egypt)

Nocturia is significantly associated with depressive symptoms in Caucasian-European men seeking medical help for sexual dysfunction without known psychiatric disorders (#149)

Eugenio Ventimiglia (Italy)

A developed simple algorithm for the decision-making on neurovascular bundle preservation does not compromise surgical margins in high risk prostate cancer (#150)

H. Tabata (Japan)

Differential DNA methylation in monozygotic twins discordant for female sexual functioning (#151)

Andrea Burri (United Kingdom)

Rates and correlates of intimacy challenges and relationship readjustment in military families (#152)

S. Wilcox (USA)

On the sexology training in the psychiatry residence in Portugal (#153)

A. Dias-Amaral (Portugal)

Love and sex with robots: ten hot topics for future medicine sexology research (#154)

A. Campagna (Italy)


02:30 p.m. - 03:30 p.m.

Podium session 11 - Sexual identity (orientation), gender identity and sexual preference

Location: Room 5 B/C in Pavilion 5
Moderators: Cecilia Dhejne (Sweden) & Sharon Parish (USA)

Is gender affirming hormonal therapy linked to aggression in transgender people? (#155)

J. Defreyne (Belgium)

Mental health indicators of non-binary young people in the United Kingdom (#156)

J. Arcelus (United Kingdom)

Self-concept in association with homo-/heterosexual identity and sexual activity - results from the German male sex-study (#157)

J.C. Baudrexl (Germany)

Estimating transgender persons’ involvement in sex work in Europe (#158)

J. Van Schuylenbergh (Belgium)

Preliminary study of a specific penile prosthesis conceived for phalloplasty, the ZSI® 475 FtM (#159)

P. Neuville (France)

Development of a decision aid for genital surgery in transmen (DA-GST) (#160)

M. Ozer (The Netherlands)

Gender congruence and psychiatric morbidity after gender-affirming health care: Relation to childhood adversities and adult stressful life events (#161)

Cecilia Dhejne (Sweden)

Neophallus penile prosthesis placement-anatomic and post-surgical challenges, device selection criteria, and proposed surgical technique (#163)

M. Garcia (USA)

Colpectomy reduces the risk of urethral fistula after urethroplasty in transgender men undergoing genital gender confirming surgery (#164)

M. Al-tamimi (The Netherlands)


03:30 p.m. - 05:00 p.m.

Take home messages and awards

Location: Auditorium II
Moderators: Maarten Albersen (Belgium) & Wayne Hellstrom (USA)

03:30 p.m. - 03:45 p.m.

Basic science

Nikolai Sopko (USA)

03:45 p.m. - 04:00 p.m.

Female sexual function

Sandrine Atallah (Lebanon)

04:00 p.m. - 04:15 p.m.

Sexology, gender and psychosexual issues

Mona Reda (Egypt)

04:15 p.m. - 04:30 p.m.

Androgens

Ronny Tan (Singapore)

04:30 p.m. - 04:45 p.m.

Erectile and ejaculatory dysfunction

Marta Skrodzka (Poland)

04:45 p.m. - 05:00 p.m.

Awards


Unmoderated Posters

Unmoderated Posters

Unmoderated Posters

Stem cell conditioned media profiles and potential uses in erectile dysfunction (#322)

Ryan Terlecki (USA)

The effectiveness of pixel co2 laser in the treatment of sexual complaints of patients with vulvovaginal atrophy (#401)

E.A.G. Pereyra (Brazil)

Study of the histological components and the development of the prostate during the fetal period (#402)

F. Sampaio (Brazil)

Surgical management algorithm for complex cases of Peyronie’s Disease with penile prosthesis implantation, modified neurovascular bundle release and single or multiple corporeal incisions and grafting with collagen fleece (#403)

E. Fernández-Pascual (Spain)

Staged urethroplasty for recurrent complex urethral strictures (#404)

B. Gvasalia (Russia)

Sexual life outcomes after radical cystectomy with external urinary derivation (#405)

K. Chaker (Tunisia)

Stability of genetic and environmental influences on female sexual functioning (#406)

Andrea Burri (United Kingdom)

Study of Correlation between family values and opinion regarding surrogacy among Taiwanese (#407)

S. Yang (Taiwan)

Structure of sexual disorders in persons with type 2 diabetes mellitus (#408)

M.G. Romaniuk (Ukraine)

Standardized lecture components in sexuality education in Japanese medical schools (#409)

M. Shirai (Japan)

The relationship between body image and marital satisfaction with the mediating role of sexual satisfaction (#410)

M.A. Ramezani (Iran)

Surgical sperm retrieval in Non-Obstructive Azoospermia(NOA) - How do we predict success? (#411)

A.K. Ponnusamy (India)

Symptoms, sexual dysfunction and psychological burden in Chinese men with chronic prostatitis/ chronic pelvic pain syndrome (#412)

J. Gao (China)

Tadalafil, dapoxetine alone or in combination for the treatment of erectile dysfunction combined with premature ejaculation (#413)

H. Zhou (China)

The implication of aortic calcification on late onset hypogonadism in patients with end stage renal disease (#414)

N. Fujita (Japan)

The importance of proper placebo-control in sexual medicine medical device trials (#415)

Michael Krychman (USA)

The prevalence and comparison of sexual dysfunction among Egyptian expatriates, Egyptian citizens, and Saudi citizens according to (ASAS-M) (#416)

A. Attaky (Saudi Arabia)

The pro-erectile and anti-fibrotic effects of the nutraceutical Revactin® are mediated by activation of the iNOS-cGMP pathway (#417)

M.G. Ferrini (USA)

The relationship between premature ejaculation and lower urinary tract symptoms in mid to old men (#418)

K. Min (Korea)

The results of introduction of national program"Men's reproductive health" in Kazakhstan (#419)

M.K. Alchinbayev (Kazakhstan)

The role of microscopic examination in the diagnosis of chronic bacterial prostatitis (#420)

D.V. Krakhotkin (Russia)

The sNHE channel in human sperm: relation with functional parameters and down-regulation in spermatozoa from patients with asthenozoospermia (#421)

Z. Zhang (China)

The impact of sacral neuromodulation on male erectile function (#422)

P. Simoes de Oliveira (Portugal)

The impact of preoperative daily PDE5 inhibitors on the early recovery of erectile function following robot-assisted radical prostatectomy (#423)

Shinichi Hisasue (Japan)

The impact of pregnancy and delivery on sexual life (#424)

I. Briedite (Latvia)

The assessment of the optimization of the erbium laser therapy protocol for treatment of erectile dysfunction (#425)

H. Kotb (Egypt)

The attitudes toward Sexual rights of transgender people and sociodemographic characteristics involved in the recognition and denial (#426)

M. Silvaggi (Italy)

The diet based on oil of Brazil nut (Bertholletia excels) minimizes the alterations on testicular morphology related to obesity in Wistar rats (#427)

C. Gallo (Brazil)

The effect of cavernous nerve traction on erectile function in rats (#428)

J.H. Liu (China)

The emergency treatment strategy and prognosis of priapism in a Chinese clinic (#429)

M. Zhang (China)

The endocannabinoid system in male reproductive organs: expression and localization of fatty acid amide hydrolase (FAAH) in the seminal vesicles and vas deferens (#430)

S. Ueckert (Germany)

The Igls-Vienna SexMed-Survy Programm - assessing the integration of sexual health aspects in disease management by various health professions and medical disciplines - the concept _ Medical University Vienna, Univ.Clinic for Surgery _ 2017 (#431)

L. Ucsnik (Austria)

The impact of liraglutide treatment on the erectile function of the diabetic rats (#432)

S. Gonultas (Turkey)

The surgical management of traumatic penoscrotal skin avulsion (#433)

H. Yao (China)

Prospective evaluation of depression and sleep disorders in patients presenting to a men’s health clinic (#434)

Faysal Yafi (USA)

Salvage of (partial) neo-urethral necrosis after phalloplasty in transgender men (#435)

M. Al-tamimi (The Netherlands)

Sampling technique and detection rates of oropharyngeal and anorectal gonorrhoea using nucleic acid amplification tests in men who have sex with men (#436)

E.P.F. Chow (Australia)

Screening for sexual dysfunction in male diabetic patients - an evidence-based review. (#437)

J. Dias (Portugal)

Scrotal trauma - results of a series of surgically treated patients (#438)

J. Torres (Portugal)

Semen quality assessment in 3425 fertile men in Guangdong province (#439)

F.P. Shu (China)

Serum testosterone in diabetic men is not linked to diabetic control (#440)

S. Giona (United Kingdom)

Serum total testosterone level is not associated with nocturia in men with erectile dysfunction without LUTS/benign prostatic (#441)

Andrea Salonia (Italy)

Severe vaginal hemorrhage requiring surgical repair after consensual sex: a retrospective review in one medical center (#442)

A. Padoa (Israel)

Risk factors for erectile dysfunction among young men – findings of a real-life cross-sectional study (#443)

Andrea Salonia (Italy)

Resveratrol attenuates metabolic, sperm and testicular changes in adult Wistar rats fed a cafeteria dietary Resveratrol attenuates metabolic, sperm and testicular changes in adult Wistar rats fed a cafeteria dietary (#444)

F. Sampaio (Brazil)

Relevance of testicular histopathology on prediction of sperm retrieval rates after a conventional bilateral multiple TESE in case of non-obstructive azoospermia (NOA) and obstructive-azoospermia (OA) (#445)

G. Cito (Italy)

Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway (#446)

B.R. Choi (Korea)

Psychological distress in a sample of men with Peyronie's Disease attending a private urology clinic in Germany (#447)

Andrea Burri (United Kingdom)

Psychopathological predictors of pedophilic sexual interest in a sample of convicted child sexual offenders (#448)

J. Carvalho (Portugal)

Quality of life after medical versus surgical castration for locally advanced or metastatic prostate cancer (#449)

K. Chaker (Tunisia)

AIDS related care for transgender people: a systematic review. (#450)

A.M. Vaitses Fontanari (Brazil)

Addressing patients sexuality - a survey of Danish health professionals attitudes, beliefs and practice (#451)

M.K. Stokholm (Denmark)

Relationship between radiation doses and development of erectile dysfunction in patients treated with permanent prostate brachytherapy for localized prostate cancer (#452)

N. Hayakawa (Japan)

Relationship between sexual dysfunction and psychological burden in men with infertility: a large observational study in China (#453)

J. Gao (China)

Sexual abuse, desired frequency of sexual activities and poor relationship with father is associated with prevalence of paraphilic preference: a study on representative sample of Czech citizens (#454)

K. Klapilova (Czech Republic)

Sexual addiction: risk factor for development neurodegenerative disorder as dementia (#455)

A. Attaky (Saudi Arabia)

Sexual and reproductive health in women undergoing mid-trimester pregnancy termination (MTPT) below 24 weeks of gestational age (GA) in a single obstetric unit in Singapore (#456)

S. Choo (Singapore)

Sexuality and family education in violent and sexual offender (#457)

V. Saladino (Italy)

Sexuality and prostatic cancer: A “Couple Ilness" (#458)

M. Falone Percivale (Italy)

A retroprospective study of the treatment of erectile dysfunction with extracorporeal shockwave therapy (ESWT) (#459)

A. Højgaard (Denmark)

Sexuality in patients undergone surgery for urological cancers (#460)

L. Lund (Denmark)

Sexuality in people suffering from schizophrenia spectrum: relationship between sexual functioning, psychopathological symptoms and global functioning (#461)

G. Ciocca (Italy)

Silicone lubricant in community clinic survey - results from the SLICC survey (#462)

Michael Krychman (USA)

Small penis anxiety: a case study of its effect on a gay man (#463)

R. Kunelaki (United Kingdom)

Socio-demographic and psychological characteristics associated to the attitude towards homoparenting (#464)

G. Ciocca (Italy)

Sexual outcomes after fracture of the penis (#465)

A. Kayal (India)

Sexual functioning in people taking antidepressants and healthy volunteers in Japan: A cross sectional online survey (#466)

Anita Clayton (USA)

Sexual function in males after radical cystectomy (#467)

J. Xiaodong (China)

Sexual behaviors in dementia patients (#468)

T. Teodoro (Portugal)

Sexual debut age according to the social economic status in Korea (#469)

S. Yoo (Korea)

Sexual disorders in women with recurrent infection of the lower urinary tracts caused by HPV infection (#470)

D.V. Krakhotkin (Russia)

Sexual dysfunction in female university student and it correlation with body image (#471)

K.C. Bragante (Brazil)

Sexual dysfunction in portuguese women with type 2 diabetes (#472)

N. Marques (Portugal)

Sexual dysfunctions in women in premenopause (#473)

O. Romashchenko (Ukraine)

Sexual education and sexual issues in male students in a secondary school: andrological perspective (#474)

G. Gentile (Italy)

Sexual function in a representative sample of Italian female university students (#475)

M. Silvaggi (Italy)

Sperm retrieval rate: comparative single surgeon results between first 30 consecutive c-TESE and first 30 m-TESE in NOA patients (#476)

A. Sacca (Italy)

The value of monitoring nocturnal penile tumescence and rigidity testing (NPTR) for three consecutive nights in the forensic identification. (#477)

Y. Zhang (China)

Sexual problems and couple disharmony in bipolar patients - a case series (#478)

N. Trovão (Portugal)

Visual patterns of sexual desire among male and female participants: an original and exploratory eye tracking study (#479)

M. Bolmont (Switzerland)

Quality of life among patients with patients with chronic renal failure (#480)

N. Ati (Tunisia)

Dienogest for the treatment of dyspareunia caused by endometriosis (#481)

L. Pkhaladze (Georgia)

Double eight plication: Decreasing recurrence rate in corrective surgery for penile curvature (#482)

Osama Shaeer (Egypt)

Sensitivity before and after gender confirming surgery on the glans penis and neoclitoris (#483)

H. Sigurjonsson (Sweden)

Urethral lithiasis after neophalloplasty (#484)

M.P. Lourenço (Portugal)

Skin bridges that occur after circumcision operation and surgical treatment: Case presentation (#485)

Selcuk Sarikaya (Turkey)

Preliminary findings on sexual functioning and urinary incontinence after radical prostatectomy (#486)

Ana Luísa Quinta Gomes (Portugal)

Exploratory study on sexual behavior and sexual satisfaction in men after radical prostatectomy (#487)

Ana Luísa Quinta Gomes (Portugal)

Shaeer's Monsplasty: A minimally invasive technique for revealing the concealed penis (#488)

O. Kamal Shaeer (Egypt)

Low-energy shock waves in treatment of erectile dysfunction. Clinical experience with the first one hundred patients in Venezuela (#489)

G. Bastidas (Venezuela)

The status of serum urotensin-II in patients with erectile dysfunction (#490)

S.K. Singh (India)

Towards the individualization of vaginal dilatation exercises: A Quantitative analysis of the variability of vaginal pressure responses (#491)

S. Knorn (Sweden)

Impact of Laparoscopic promontofixation on sexuality and quality of life (#492)

M. Amri (Tunisia)

Bodily beliefs and bodily expression of emotions among a group of iranian women with vaginismus (#493)

M. Molaeinezhad (Iran)

Penile lengthening with porcine small intestinal submucosa grafting in Peyronie’s disease treatment: long-term surgical outcomes, patients satisfaction and dissatisfaction predictors. (#494)

A. Morgado (Portugal)

Oversizing: Penile prosthesis implantation as per the erect length by intra-cavernosal injection of vasoactive material (#496)

O. Kamal Shaeer (Egypt)

Penile size prediction post-prosthesis implantation via intraoperative intracorporeal injection; a novel tool (#497)

A.M. Ragheb (Egypt)

Sexual dysfunction among postmenopausal Tunisian women (#498)

N. Ati (Tunisia)

Effect of norbornene derivative in corpus cavernosum relaxation, as 5-HT1A agonist and 5-HT2A antagonist (#499)

A.F.O. Justo (Brazil)

Sexual dysfunction in women with locally advanced or metastatic cancer – a cross sectional study (#500)

L. Campos (Brazil)

Primary urethral malignant melanoma that is complicating sexual intercourse (#501)

Selcuk Sarikaya (Turkey)

Why don’t you share your satisfaction with me? (#502)

Z. Shahvari (Iran)

First sexual intercourse: age, personal experiences, sexual behavior, attitudes and regrets among women (#503)

I. Briedite (Latvia)

Pleasure Dissociative Orgasmic Disorder: a case report and literature review (#504)

B.C. Barata (Portugal)

Purse-string closure of penile implant corporotomies: a needleless, water-tight technique (#505)

Osama Shaeer (Egypt)

The importance of communication between doctor and patient in the management of Erectile dysfunction – a clinical study of 120 cases (#506)

M. Amri (Tunisia)

Withhold expressing sexual expectations: a qualitative study in Iranian women (#507)

Z. Shahvari (Iran)

Continuance of marital life: the hidden dimension of sexual relationship in marriage; a qualitative study in Iranian Women (#508)

Z. Shahvari (Iran)

The impact of attachment style on sexual functioning among men and women (#509)

M. Amri (Tunisia)

Reflections on cost-effectiveness of colagenase in the treatment of Peyronie's Didease in a public system (#510)

C. Conde Redonde (Spain)

Clinical patterns: The big difference between Peyronie´s disease and Chronic traumatic cavernosophaty (CTC) (#511)

J.F. Uribe (Colombia)

Penile trauma secondary to aggression - particularities and prognosis (#512)

R. Multescu (Romania)

Epidemiology and impact of erectile dysfunction among 120 elderly patients (#513)

M. Amri (Tunisia)

Sperm DNA integrity in patients with varicocele: relationships between DNA fragmentation and bulk semen parameters (#515)

V. Alargkof (Bulgaria)

Mental health status of treatment seeking young transgender people: a comparative study between young transgender people and the general population (#516)

J. Arcelus (United Kingdom)

Who drops out from the UCM therapy? Psychological, social and clinical factors related to continuation of the UCM therapy (#517)

S. Jakima (Poland)

When do primary care doctors actively ask for erectile dysfunction (ED) their patients in 50? (#518)

G. Tsigarovski (Bulgaria)

What evidence is there for physiotherapeutic treatments, applied to pelvic floor, for whatever pelvic floor dysfunction in people with Multiple Sclerosis? A systematic review (#519)

A.B. Martín-González (Spain)

Web promotion of da Vinci robotic prostatectomy exhibits varying sexual health information (#520)

K. Matsushita (Japan)

Vibrator-assisted start-stop exercises in conjunction with body awareness training improve premature ejaculation symptoms: a randomized waiting list controlled study (#521)

D. Ventus (Finland)

Vacuum erection device reduce peyronie-like plaque in PD rat model via TGF-beta/SMAD signaling pathway (#522)

J. Yuan (China)

Vacuum erection device and Phosphodiesterase5 inhibitors for the treatment of erectile dysfunction: a systematic review and meta analysis of randomized controlled trials (#523)

Q. An (China)

Vaccinating male individuals against human papillomavirus - an evidence-based review (#524)

J. Dias (Portugal)

Utility of elastography in erectile dysfunction and its relationship with doppler ultrasound (#525)

L.M. Helguero-Santin (Peru)

Types of female prostate gland (#526)

O. Romashchenko (Ukraine)

Tribulus terrestris can change the morphology of the penis? A study developed in a model of pre-disposition to benign prostatic hyperplasia (#527)

F.J. Sampaio (Brazil)

Treatment of chronic recurrent bacterial prostatitis with multiple drug resistance to antibacterial agents (#528)

D.V. Krakhotkin (Russia)

Treating erectile dysfunction with a combination of low-intensity shock waves (LISW) and platelet-rich plasma (PRP) injections (#529)

A. Ruffo (Italy)

Towards a globally shared taxonomy of the different conditions diagnosed as unconsummated marriage (#530)

M. Silvaggi (Italy)

Improvement of erectile function by intracavernous injection of hepatocyte growth factor in a rat model of erectile dysfunction after cavernous nerve injury (#531)

S. Yoo (Korea)

Time to first infertility diagnosis and sperm retrieval rate: results after 30 consecutive micro TESE in NOA patients (#532)

A. Sacca (Italy)

Therapeutic effect of low-intensity pulsed ultrasound on erectile dysfunction: A multicenter clinical trial (#533)

Zhong-Cheng Xin (China)

A preliminary study of etiological factors in patients with calculi-associated seminal vesiculitis, based on calculus analysis in 6 patients (#534)

G. Wang (China)

A novel therapeutic method for azoospermia resulted from distal deferential obstruction (#535)

T. Jing (China)

Brachyterapy and sexual morbidity (#536)

G. Falcao (Portugal)

Dorsal phalloplasty: Revealing the concealed penis along with penile prosthesis implantation (#537)

O. Kamal Shaeer (Egypt)

Effects of female genital mutilation/cutting on birth - a retrospective case-control-study (#538)

D. Dörfler (Austria)

Evaluation of sexual dysfunction after radical cystectomy for muscle invasive bladder cancer in male patients and their spouses with orthotopic ileal neobladder or ileal conduit (#540)

M.E. Haque (Bangladesh)

"Do Surgeons performing cytoreductive therapy, such as HPEC and PIPAC, in peritoneal cancer patients adress troubled sexual health in disease-management-programs? Igls-Vienna-SexMed-Survey-Program: Participants' self-assessment-results at the HIPEC/PIPAC-

L. Ucsnik (Austria)

Overexpression of the calcium-binding protein regucalcin mitigates the age-associated changes in oxidative stress and semen quality (#542)

A.M.S. Silva (Portugal)

Extra-Corporal Trans-Septal Penile Prosthesis Implantation for Cases of Corporal Fibrosis (#543)

Osama Shaeer (Egypt)

Do health professionals in physical medicine and rehabilitation adress sexual health issues during the process of patients' treatment and recovery? Igls-Vienna-SexMed-Survey-Program: Participants' self-assessment-results at the annual Austrian Congress of

L. Ucsnik (Austria)

Is troubled sexual health part of interventional radiologists' patient-management? Igls-Vienna-SexMed-Survey-Program: Health professionals' self-assessment-results at the annual Three-Nations-Conference of the Interventional Radiological Societies, IROS,

L. Ucsnik (Austria)

Assessment of predictors of abnormal peak systolic velocity and end diastolic velocity in penile doppler ultrasound (#546)

S. Giona (United Kingdom)

Sexuality in multicultural Portugal – A cross-cultural survey of sexual and reproductive health indicators between Portuguese, Brazilians, Cape Verdeans, Angolans, Guineans and Sao Tomeans living in Portugal (#547)

A. Barroso (Portugal)

A comparative study of changes in sperm parameters before and after testicular tumor surgery (#548)

H. Iwai (Japan)

A comparison of bovine pericardium and tachosil graft procedure for Peyronie's Disease (#549)

C. Fliatouras (Greece)

A Meta-analysis and systematic review of dapoxetine for treatment of premature ejaculation (#550)

Q. An (China)

A novel algorithm for assessment of penile fibrosis in men with erectile dysfunction (#551)

Irwin Goldstein (USA)

A novel method of penoplasty with“T” circus incision and three - point fixation for concealed penis (#552)

G. Wang (China)

The ‘heat’ goes away: sexual disorders of married women with female genital mutilation /cutting in 52 (#553)

T. Esho (Kenya)

Do clinical psychologists at Medical University Vienna integrate patients' sexual problems in routine consultation_self-assessment's results, meeting, Vienna, November 2017 (#554)

L. Ucsnik (Austria)

Do young surgeons in training in Europe and Asia integrate sexual health in daily treatment - self-assessment-results at the Davos Courses in Gastrointestinal Surgery, Davos, April 2017 (#555)

L. Ucsnik (Austria)

Does percutaneous epididymal sperm aspiration actually cause epididymal obstruction? (#556)

C. Cairoli

Doppler test in penis flaccid state to asses erectile dysfunction severity and shockwave treatment outcomes (#557)

M. Gatkin (Russia)

Analysis of early prognosis and complication of laparoscopic bilateral inguinal lymph node dissection in penile cancer (#558)

Y. Zhang (China)

Dysasthetic penile scrotodynia - a psychosexual somatoform disorder (#559)

V. Long (Singapore)

Early erotization as a predictor of hypersexuality in depressive mood states (#560)

N. Nersisyan (Armenia)

Analysis of unsuccessful treatment of lifelong premature ejaculation with dapoxetine (#561)

J. Guo (China)

Effect of liraglutide on streptozotocin-induced diabetic rat testis (#562)

S. Sulejman (Turkey)

Do vascular surgeons in Austria integrate patients' sexual issues in routine surgical procedures and vascular disease management - self-assessment-results at the annual congress of the Austrian society for vascular surgery, St Wolfgang, October 2017 (#563

L. Ucsnik (Austria)

Do socioeconomic factors influence the pathogenesis of erectile dysfunction through modifiable risk factors? (#564)

M. Womperski (Poland)

Do doctors in 3-year-training for family medicine specialisation integrate patients' sexual problems in routine management - medical self-assessment-results at a weekly lecture, Vienna, April 2017 (#565)

L. Ucsnik (Austria)

Do doctors in angiology/ vascular medicine tackle sexual health problems in patients' routine-treatment in Austria - survey on doctors self-assessing daily routine at the international Angiologic Academy Vienna-Berlin, Vienna, June 2017 (#566)

L. Ucsnik (Austria)

Do doctors specialising for training in health ressorts integrate sexual health problems in daily patient-managment _ self-assessment results at the annual training-course for doctors in health ressorts_Bad Gastein, March 2017 (#567)

L. Ucsnik (Austria)

Do doctors treating obesity integrate sexual health problems in daily patient-managment _ self-assessment results at the annual congress of the Austrian Society of Obesity_Vienna, October 2017 (#568)

L. Ucsnik (Austria)

Do endocrine surgeons integrate sexual health problems in daily surgical managment _ self-assessment results at the annual Austrian Congress of Surgeons, endocrine working-sessions_Vienna, June 2017 (#569)

L. Ucsnik (Austria)

Do experienced colorectal surgeons from Europe, America and Asia integrate sexual problems in daily cancer management -results from a self-assessing survey at Congress of the European Federation for ColoRectal Cancer, Vienna, April 2017 (#570)

L. Ucsnik (Austria)

Do experts in breast cancer ingetrate patients' sexual issues in routine management - medical self-assessment-results at the 15th international maritime meeting of the Austrian society for senology, Mallorca, Spain (#571)

L. Ucsnik (Austria)

Do health professionals integrate sexuality in managing patients' continence and stoma-therapy in Austira - results self-asessment-survey at the annual Austrian Continence Meeting, Linz, October 2017 (#572)

K. Buchner-Jirka (Austria)

Effectiveness and safety of microsurgical varicocelectomy for treating nutcracker phenomenon associated varicocele (#573)

Xiaodong Jin (China)

Effectiveness of combined therapy Impaza and PDE5 inhibitors in prophylaxis post-traumatic erectile dysfunction (#574)

D.V. Krakhotkin (Russia)

Effectiveness of physiotherapeutic techniques on females with pain-related sexual dysfunctions: a systematic review (#575)

B. Rojo (Spain)

Expressions of TRPV1 and TRPA1 in the dorsal root ganglion in the rat model of orchialgia (#576)

T. Xiangan (China)

Extracorporeal shock-wave therapy (ESWT) in treatment of ED: results of sham-controlled study (#577)

L. Spivak (Russia)

Factors influence copper intrauterine device eexual acceptability in Egypt (#578)

H. Aly (Egypt)

Factors predicting paternity after varicocele surgery (#579)

A. Rafi (Pakistan)

Family history regarding cardiovascular disease and diabetes and erectile dysfunction in patients with coronary artery disease (#580)

M. Womperski (Poland)

Female (Chinese nurses) sexual function and the impact of kids’ return on it during the summer holiday (#581)

Y. Zhang (China)

Female genital mutilation among middle aged Egyptian women and its impact on their sexual function (#582)

D. Elkowessny (Egypt)

Female sexual dysfunction among Greek women with multiple sclerosis: correlations with organic and psychological factors (#583)

M. Tzitzika (Greece)

Experimental assessment of platelet-rich plasma efficacy for spermatogenesis correction in the rat: evaluation of two experimental models (#584)

M.V. Epifanova (Russia)

Experience of community pharmacists in providing advice about vulvo-vaginal complaints (#585)

S. Grinceviciene (Belgium)

Effectiveness of the use of silicone penile prosthesis in the prevention of vaginal stenosis after high dose rate brachytherapy (#586)

K.C. Bragante (Brazil)

Effects of Brazil nut (Bertholletia excelsea) oil-based diet on penile morphology of Wistar rats’ (#587)

C. Gallo (Brazil)

Efficacy and safety of Holmium laser enucleation of prostate (HoLEP) in patients with underlying neurologic disease (#588)

M. Kim (Korea)

Efficacy and safety of low dose testosterone ointment therapy for late-onset hypogonadism patients (#589)

Toshiyasu Amano (Japan)

Employment of avanafil in a surrogacy program (#590)

F. Dimitriadis (Greece)

Endocrine surgeons self-assessing the setting for actively adressing patients' sexuality and impact on their help in routine-treatment at annual Austrian Congress for Surgery, Vienna, June 2017 (#591)

L. Ucsnik (Austria)

Erectile dysfunction in young men (up to 40 years old). What does organic or psychogenic predominate? (#592)

D. Ion (Moldova)

Evaluation of drug abuse in male patients with sexual dysfunction in Upper Egypt: a cross sectional study (#593)

A. Abdelhamed (Egypt)

Female sexual function in obese women and associated factors (#594)

M. Kong (Korea)

Analyzes of male sexual function and sperm parameters in contusive spinal cord injured rats: therapeutic efficacy of mucuna pruriens(Linn.) (#595)

W.S. Khayinmi (India)

Can the testicular parenchyma fibrosis be a predictor of testicular failure in the patients with varicocele? (#596)

L. Pucci (Italy)

Analysis of our results in the treatment of Peyronie´s disease with Clostridium histolyticum collagenase and modeling using penis extender (#597)

M. Alonso-Isa (Spain)

Chronic traumatic cavernosopathy (CTC). The new penile fibrous disease (#598)

J.F. Uribe (Colombia)

Clinical characteristics of 1128 patients with premature ejaculation: a cross-sectional study from 16medical institutions in China (#599)

L. Hongjun (China)

Clinical indications for penile prosthesis implantation: data from the national prospective registry of penile prosthesis implantation “INSIST-ED” (#600)

F. Dehò (Italy)

Clinical outcome/patient and partner satisfaction after penile implant surgery (#601)

Koenraad Van Renterghem (Belgium)

Clinical outcomes of androgen replacement therapy (ART) in Japanese patients with late-onset hypogonadism(LOH) syndrome -comparison of total and free testosterone value (#602)

K. Kuratsukuri (Japan)

Clinical trial with natural extracts from Lycium chinense for eugonadal men with late-onset hypogonadism-related symptoms: placebo-control, double-blind, randomized study (#603)

W.J. Bae (Korea)

Body image is affected by vasectomy, showing higher scores in Self-aggrandizement after surgery (#604)

K. Lamacova (Austria)

Biochemical markers and clinical aspects of fluids expelled by women during sexual activities (#605)

Z. Pastor (Czech Republic)

Are masculinity and femininity correlated with attachment styles? a pilot study with bem sex role inventory and attachment style questionnaire (#606)

G. Ciocca (Italy)

Are sexual dysfimctions part of integrated consultation of Austrian's psycho-oncologists from various disciplines ? Self-assessment-results at the annual meeting auf Austrian psychooncologists, Gmunden, May 2017 (#607)

L. Ucsnik (Austria)

Assessment of female sexual health in Kazakhstan (#608)

M.K. Alchinbayev (Kazakhstan)

Assessments of mental health status of premature ejaculation (PE) patients by Minnesota Multiphasic Personality Inventory compared with non-PE male control (#609)

M. Lu (China)

Attachment style, alexithymia and sexual functioning among pregnant and nonpregnant women (#610)

G. Ciocca (Italy)

Autologous dermal tissue grafting for Peyronie’s Disease with large tunica albuginea defects (#611)

Koichi Nagao (Japan)

Best practice in vulvodynia—an evidence-based literature review (#612)

D. Botta (Italy)

Best with daily tadalafil in terms of lower urinary tract symptoms: What is the current situation among Turkish men? (#613)

A.V. Dikmen (Turkey)

Comparative analysis of penile prosthesis implantation in patients with vasculogenic aetiology versus radical prostatectomy (#614)

J. Torremadé Barreda (Spain)

Comparative analysis of the natural history of de novo Peyronie’s Disease versus post-radical prostatectomy Peyronie’s Disease (#615)

H. Bernie (USA)

Comparative analysis of treatment strategies for distal and middle hypospadias (#616)

M. Lu (China)

Cross-sectional association between testosterone and metabolic syndrome (#617)

M. Kim (Korea)

Daily Low dose Tadalafil in treatment of Chronic prostatitis/Chronic pelvic pain syndrome: randomized controlled study of efficacy and safety (#618)

A. Abdalla El Sayed Hassan (Saudi Arabia)

Defining polyamory: a thematic analysis of lay people's definitions (#619)

Patricia Pascoal (Portugal)

Detection of neurogenic erectile dysfunction in diabetic patients with Uroflowmetry (#620)

D.J. Nale (Serbia and Montenegro)

Diminished fronto-limbic connectivity in non-pedophilic child sexual offenders (#621)

M. Veit (Germany)

Do Austrian enterostoma- and continence consultants integrate sexual health problems in daily routine - self-assessment results at the annual meeting of the Austrian enterostoma and continence consultants, October 2017, Linz, Austria (#622)

K. Buchner-Jirka (Austria)

Do Austrian experts managing chronic inflammatory disease integrate troubled sexuality and intimacy in daily routine - survey at the annual symposium Crohn Colitis, Bad Ischl, Austria, September 2017 (#623)

L. Ucsnik (Austria)

Do Austrian pain-nurses integrate sexual health problems in daily pain-management and -care- results at the annual congress of the Austrian Association for Pain,April 2017, Gmunden, Austria (#624)

R. Schukro (Austria)

Correlation between PTEN expression and prostate cancer in Chinese population: a meta-analysis (#625)

Q. An (China)

Correlation between penile deformity and perceived partner bother in men with Peyronie’s Disease (#626)

E. Miranda (USA)

Comparing plaque morphology between men developing Peyronie’s Disease (PD) after radical prostatectomy (RP) to that of de novo Peyronie’s Disease patients (#627)

H. Bernie (USA)

Comparing the outcome and adverse events in malleable versus inflatable penile implants (#628)

M. Habous (Saudi Arabia)

Comparison of lower urinary tract symptoms and sexual function response to convective radiofrequency thermal therapy of prostate (Rezûm®) to MTOPS study cohort (#629)

Kevin McVary (USA)

Comparison of national institutes of health-chronic prostatitis symptom index with international index of erectile function-5 in men with chronic prostatitis/chronic pelvic pain syndrome: A large cross-sectional study in China (#630)

J. Gao (China)

Comprehensive in-vivo biomechanical study of IPP function dependent on length of RTE (#631)

J.J. Wallen (USA)

Consecutive nightly recordings are required for the accurate monitoring of nocturnal erections (#632)

Y. Zhang (China)

Contemporary use of non-hydraulic penile prosthesis in patients with erectile dysfunction: data from the national prospective registry of penile prosthesis implantation “INSIST-ED” (#633)

F. Dehò (Italy)

Convective radiofrequency thermal therapy (Rezum®) effectively treats lower urinary tract symptoms due to benign prostatic hyperplasia regardless of obesity while preserving erectile and ejaculatory function (#634)

Kevin McVary (USA)

Do Austrian Radio-Oncologists integrate sexual health in daily cancer-treatment? Self-assessment-results at the annual meeting of the Austrian Society for Radio-Oncology, Linz, October 2017 (#635)

L. Ucsnik (Austria)

First ever case report of priapism secondary to retroperitoneal fibrosis (#636)

A. Rafi (Pakistan)

Knowledge and perception of sexual health among random Saudi population (#637)

H. Alkhudairi (Saudi Arabia)

May social media be a tool in promoting sexual health? Youth’s use, professional’s attitudes and current sexual education programs (#638)

F. Aversa (Italy)

Medication utilization in patients receiving phosphodiesterase type 5 inhibitor for erectile dysfunction (#639)

W.Y. Tang (USA)

Medico-legal evaluation of patients with genital disorders in Upper Egypt: a preliminary data. (#640)

A. Abdelhamed (Egypt)

Meet the needs of sexual desire, sexual satisfaction in long term care in Taiwan (#641)

K.H. Kuo Hung (Taiwan)

Micrisurgical penile denervation (Selective Neurotomy) for treatment of severe life long premature ejaculation (#642)

O. Knigavko (Ukraine)

Mindfulness in sex therapy: a comprehensive review (#643)

A. Villena (Spain)

Multicenter prospective study of patients with Peyronie's disease (PD) who underwent incision or partial-plaque excision with collagen-fibrinogen-thrombin fleece grafting (#644)

E. Fernández-Pascual (Spain)

Nerves and vessels of the penis are altered by a diet with vitamin-D restriction in Wistar rats (#645)

C. Gallo (Brazil)

Management of traumatic rupture of the corpora cavernosa (#646)

Y. Ouanes (Tunisia)

An outcomes analysis of 47 penile prosthesis implantations after cistoprostatectomy for muscle-invasive bladder cancer: a multicentric study (#647)

Marco Falcone (Italy)

Low-intensity pulsed ultrasound therapy as a novel treatment for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled pilot study (#648)

Z. Wang (China)

Learning curve in microdissection testicular sperm extraction: a single surgeon experience (#649)

A. Franceschelli (Italy)

Let's talk about sex(uality) in the medical curricula (#650)

R. Ferreira Carvalho (Portugal)

LISWT might improve the genitoperineal sensation and erectile dysfunction In neurogenic and diabetic patients (#651)

Jawad Feghali (Lebanon)

Long term follow up of patients operated for penile cancer : A retrospective survival bicentric study (#652)

J.E. Terrier (France)

Long-term surgical, functional and patients’ reported outcomes of the turin's corporoplasty: results from a tertiary referral center experience (#653)

F. Marco (Italy)

Long-term results of patient satisfaction after low-intensity shockwave treatment (Li ESWT) of erectile dysfunction and Peyronie's disease in an urological private practice (#654)

C. Ratz (Germany)

Longer length improvement and more covert incision: a novel “six stitches” procedures for pediatric concealed penis (#655)

X.J. Su (China)

Low-intensity extracorporeal shock wave treatment improves erectile function in non-responder PDEi5 patients: a systematic review (#656)

J.A. Grandez-Urbina (Peru)

Nomogram to predict the outcomes of intracytoplasmic sperm injection (ICSI) (#657)

H. Salem (Egypt)

Non-degloving surgical technique with double dorsal-ventral patch graft and penile prosthesis placement for Peyronie's Disease (#658)

J. Clavell Hernandez (USA)

An antidepressant effect of Tadalafil 5mg once daily in male LUTS and ED (#659)

M. Kimura (Japan)

Photoselective laser vaporization of the prostate: pronounced negative effect on the ejaculatory function (#660)

O. Vintoniv (Ukraine)

Possibility to use evaluation of cognitive error frequency in the clinical practice for women suffering with lifeling vaginismus in Georgia (#661)

Z. Marshania (Georgia)

Preserving sexual function after bone marrow transplant (#662)

W. Vanselow (Australia)

Prevalence of coital incontinence in sexual active women with and without urinary incontinence (#663)

V. Skoric (Serbia and Montenegro)

Prevalence of self-reported erectile dysfunction at first medical assessment in men with Peyronie’s disease – Preliminary findings of a real-life cross-sectional study (#664)

Andrea Salonia (Italy)

Prevalence of vaginal stenosis in the physical therapy evaluation after High Dose Rate Brachytherapy at a referral center in southern Brazil (#665)

K.C. Bragante (Brazil)

Previous pelvic radiation therapy is the single strongest risk factor for penile prosthesis infection. Data from a large monocentric series (#666)

C. Ceruti (Italy)

Profile of candidates to penile prosthesis implantation for ED; pooled analysis from two prospective population-based registry (#667)

F. Dehò (Italy)

Peyronie's Disease is common in poorly controlled diabetics but is not associated with the metabolic syndrome (#668)

M. Habous (Saudi Arabia)

Perioperative management strategies for penile prosthesis implantation - data from the prospective national registry “INSIST-ED” (#669)

F. Dehò (Italy)

Percutaneous angioplasty of internal pudendal arteries in the treatment of erectile dysfunction not responsive to pharmacological therapy. Our initial experience in five patients (#670)

F. Migliorini (Italy)

Parafilias: analysis of Brazilian scientific productions, in Portuguese language, in the period 2007-2017 (#671)

C. De Garcia (Brazil)

Pattern of surgical care of patients with erectile dysfunction: pooled analysis from two prospective population-based registry (#672)

F. Dehò (Italy)

Penile augmentation in patient with Peyronie's disease. How to improve penile lenght and width with circular and longitudinal grafting and penile implant (#673)

A. Ruffo (Italy)

Penile erection induced by scoparone from Artemisia capillaris through NO-cGMP signaling pathway (#674)

B.R. Choi (Korea)

Penile prostheses reservoire complications: non-contrast Ctscan assessment (#675)

L. Pujol (Spain)

Penile revascularization surgery in patients with diabetic erectile dysfunction: long term results (#676)

O. Kayigil (Turkey)

Penile size (length and girth) in relation to somatometric parameters and hormonal profile among Egyptian normal adults (#677)

H. Salem (Egypt)

Perceived addiction to online pornography and sexual attitudes in Portuguese college students (#678)

A. Gomes (Portugal)

Proposal of a new rehabilitation protocal based on the use of intracavernous injections and Tadalafil: preliminary results from a pilot study (#679)

Eugenio Ventimiglia (Italy)

Jealousy in heterosexual and homosexual individuals (#680)

K. Potyszova (Czech Republic)

Fluorescence in situ hybridization sperm examination in male infertility (#681)

I.B. Mansurova (Kazakhstan)

Hormonal contraceptives and sexual self-schema in women (#682)

K. Nowosielski (Poland)

How to pay attention on sexual dysfunction in Japanese patients with late-onset hypogonadism patients? (#683)

Toshiyasu Amano (Japan)

Hypersexuality: what do we know by now? (#684)

P.A. Azevedo (Portugal)

Icariin improves SHR erectile function by inhibiting eNOS uncoupling (#685)

Rui Jiang (China)

Identifying needs on teaching/learning sexuality in a Portuguese medical school (#686)

N. de-Lacerda (Portugal)

Idiopathic male infertility - comparative study of the efficacy of empiric therapy with Clomiphene and Spermox ® (#687)

A. Cordeiro (Portugal)

IIEF as a practical tool for male sexual problems differentiation (#688)

I. Rahne Otorepec (Slovenia)

Illustrated evaluation of scientific productions of sexual medicine researchers during 2012 till the end of 2016 (#689)

M. Lotfipanah (Iran)

HIV-related healthcare needs and access barriers for Brazilian transgender and gender diverse people (#690)

A.M. Vaitses Fontanari (Brazil)

High serum testosterone is associated with poor pathological outcomes in patients with prostate cancer in Japanese populations (#691)

Y. Horiguchi (Japan)

High field MRI evaluation of different plaque property in Peyronie’s Disease (#692)

Y. Zhang (China)

Frequency of sexual intercourse between first and third trimester of pregnant women (#693)

H. Fejza (Kosovo)

Fresh human cadaver vaginoplasty surgical prosections to guide surgical technique, post-operative care, and the design of a novel neovaginal dilator and douching device (#694)

M. Garcia (USA)

Gender dysphoria and eating disorders in adolescence: two case report (#695)

Alessandra Fisher (Italy)

Gender roles and sexual functioning in people of different sexual orientations (#696)

G. Arbanas (Croatia)

General urologists' attitudes towards the use of collagenase clostridium histolyticum (Xiapex) in Peyronie's Disease (#697)

R. Tal (Israel)

Genital responses to sexual imagery in women with and without sexual problems: preliminary findings (#698)

L. Krejcova (Czech Republic)

Genito-pelvic pain disorders and psychological functioning: a comparative study between patients with vulvodynia and endometriosis (#699)

V. Rossi (Italy)

Gyneacological sexological assessment of female sexual dysfunction in 58 (#700)

G. Simetinger (Slovenia)

Immediate salvage of purulent inflatable penile prostheses can be safely done in insulin-dependent type II diabetics and the chronically immunosuppressed (#701)

E.C. Carlos (USA)

Impact of camera deviation on curvature assessments using goniometer and 2D photographies (#702)

E. Miranda (Brazil)

Implicit associations towards pornographic stimuli in hypersexual disorder (#703)

J. Engel (Germany)

Infidelity, impulsivity, attachment and distorted cognitions (#704)

R. Ignat (Romania)

Influence of 5a-reductase inhibitor (5-ARI) usage on the reproductive function of married men (#705)

S. Song (Korea)

Influence of socioeconomic factors on the presence and intensity of erectile dysfunction in men with coronary artery disease (#706)

M. Womperski (Poland)

Informative leaflet about neovaginal dilatation after MtF reassignment surgery: the importance of correct management of dilatation programme (#707)

M. Di Grazia (Italy)

Integration of sexual medicine field in the care of patients with HIV (#708)

M. Bolmont (Switzerland)

Intracavernosal injection (ICI) therapy - Efficacy, side effects and dropouts: experience of a single institution (#709)

B. Graça (Portugal)

Investigating the correlation between vitamin D and metabolic syndrome (#710)

S. Giona (United Kingdom)

Is free testosterone good or evil for lower urinary tract symptoms? : analysis of a Japanese community-based study (#711)

K. Kobayashi (Japan)

Individual delay-discounting rate in a patients with hypersexual disorder (#712)

M. Smas-Myszczyszyn (Poland)

Isoflurane inhalation anesthesia should be a new requirement in intracavernosal pressure detection—the gold standard of erectile function assessment (#713)

J. Yuan (China)

Increased prevalence of premature ejaculation on a 10-year interval web-based survey (#714)

S. Yoo (Korea)

Increased risk of sexual dysfunction among unemployed women: a systematic review (#715)

M.J. Jabat (Switzerland)

Improve sexual function with vaginal rejuvenation surgery (#716)

M. Lau (USA)

increased circunference of penis with polimetiltacrilato (10%) folow-up of 2 years (#717)

M. Menezes (Brazil)

increase in penile circumference and quality of life (#718)

M. Menezes (Brazil)